Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Coronary heart disease BASKET).php on line 2
Heart (Coronary heart disease BASKET)
LE WE PMID CA
Heart (Coronary heart disease BASKET)17Herz (Koronare Herzkrankheit allg)

Abciximab ttGPIIbIIIa

Action potential

Adenosine

Angiogenesis

Arteria radialis

Atherosclerosis (BASKET)

Atherosclerosis (peripheral vessels)

Autoantibodies Anti Phospholipid Anti Cardiolipin Anti beta 2 GP

Autophagy

Bivalirudin

Calcification

Cardiovascular risk

Cholesterol embolism

Choline

Clopidogrel

CNS (Stroke BASKET)

COPD

Craniofacial dysostosis

CXCR4

Cystatin C

Diabetes mellitus (Involvement heart and vessels)

Dronedarone

Electron tomography

Endothelial dysfunction

Endothelial progenitor cell capture stents

Enoxaparin

Eptifibatide

Erectile dysfunction

ERS UFR (Diseases)

Erythropoietin

Extrinsic compression of the left main coronary artery

Fondaparinux

Glucose (Blood glucose)

Heart (Anatomy)

Heart (Arrhythmia)

Heart (Atrial fibrillation)

Heart (Cardiomyopathy dilated)

Heart (Cardiomyoplasty)

Heart (Coronary angiography)

Heart (Coronary heart disease BASKET)

Heart (Coronary vessels Anatomy)

Heart (CT)

Heart (Echocardiography)

Heart (Electrocardiography)

Heart (Imaging)

Heart (MRT)

Heart (PET)

Heart (Radiation therapy)

Heart (Stress Echocardiography)

Heart (Takotsubo s syndrome)

Heart (Traumatology)

Heart failure (acute)

Heart failure (chronical)

Hedgehog

Heparin LMW

Intraaortal blood pump IABP

Ischemia reperfusion

Ivabradine

Kawasaki s disease

Kidney (Chronic renal failure)

KIF6

Lipocalin type PGD synthase

Low back pain

Mannose binding lectin MBL

Metabolic syndrome

Myeloperoxidase

Myxoma virus

Nab paclitaxel

Nanog

Oct4

ORP150

Pain (Neurophysiology)

Prasugrel

Procalcitonin

Pulmonary hypertension

RAAS (Local Heart)

Ranolazine

Receptor (Histamine)

Regadenoson

Regeneration of tissues and other biologic structures

Remodeling

SDF1

SERP1

Spinal cord (Electrostimulation)

SSEA1

Statin

Stem cell (Adult)

Sudeck s dystrophy

Taurine

Tenecteplase

Thorax (Pain)

Thrombopoietin

Ticagrelor

Troponin

Ultrasound (intravascular)

uPA

Very small embryonic like cells

2005  
1
Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique.
[15784781] Psychosom Med 67(2): 179-86 (2005)
1982  
2
Psychosocial intervention in coronary artery disease: a review.
[6755526] Psychosom Med 44(4): 363-87 (1982)
2003  
3
Pathophysiology and investigation of coronary artery disease.
[12742929] BMJ 326(7397): 1027-30 (2003)
1983  
4
2006  
5
Non-ST segment elevation acute coronary syndromes: A comprehensive review.
[17100031] South Med J 99(10): 1103-10 (2006)
2006  
6
Non-ST segment elevation acute coronary syndromes.
[17100021] South Med J 99(10): 1053-4 (2006)
2000  
7
Left main coronary artery rotational atherectomy and stenting.
[10798513] South Med J 93(4): 415-23 (2000)
1976  
8
The variant form of angina pectoris.
[769170] South Med J 69(3): 345-52 (1976)
2009  
9
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
[19286891] QJM 102(6): 369-78 (2009)
2006  
10
The treatment of coronary artery disease in patients with chronic kidney disease.
[17040978] QJM 99(11): 723-36 (2006)
2006  
11
ECG diagnosis of acute ischaemia and infarction: past, present and future.
[16495300] QJM 99(4): 219-30 (2006)
2005  
12
Pitfalls and problems of relying on serum troponin.
[15820969] QJM 98(5): 365-71 (2005)
2005  
13
Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction.
[15760923] QJM 98(4): 275-82 (2005)
2001  
14
Revascularization for cardiogenic shock.
[11181981] QJM 94(2): 57-67 (2001)
1969  
15
Contributions of electron microscopy to the study of myocardial ischaemia.
[4908552] Bull World Health Organ 41(6): 865-72 (1969)
2006  
16
Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography.
[16832004] Arch Intern Med 166(13): 1391-5 (2006)
2006  
17
Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
[16606819] Arch Intern Med 166(7): 806-11 (2006)
2003  
18
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
[12767950] Arch Intern Med 163(10): 1145-53 (2003)
2001  
19
Low-molecular-weight heparins in the treatment of acute coronary syndromes.
[11427095] Arch Intern Med 161(12): 1484-90 (2001)
2001  
20
Antithrombotic therapy in patients with acute coronary syndromes.
[11295956] Arch Intern Med 161(7): 937-48 (2001)
2000  
21
Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.
[10737274] Arch Intern Med 160(6): 749-58 (2000)
2000  
22
Unstable angina: current concepts of pathogenesis and treatment.
[10632302] Arch Intern Med 160(1): 25-37 (2000)
1999  
23
Low-molecular-weight heparins in the management of acute coronary syndromes.
[10493315] Arch Intern Med 159(16): 1849-57 (1999)
2007  
24
Myocardial infarction: contemporary management strategies.
[17598815] J Intern Med 262(1): 59-77 (2007)
2009  
25
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
[19841485] Neth J Med 67(9): 284-94 (2009)
2008  
26
Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?
[18491435] Cleve Clin J Med 75(4): 289-95 (2008)
2007  
27
Understanding and minimizing late thrombosis of drug-eluting stents.
[17333640] Cleve Clin J Med 74(2): 129-36 (2007)
2003  
28
Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor?
[12549724] Cleve Clin J Med 70(1): 46-8 (2003)
1998  
29
Coronary artery disease in women.
[9870124] Can Fam Physician 44(): 2709-17 (1998)
1994  
30
Acute myocardial infarction in the young adults.
[8091795] Yonsei Med J 35(2): 184-9 (1994)
2005  
31
Perioperative myocardial infarction--aetiology and prevention.
[15665072] Br J Anaesth 95(1): 3-19 (2005)
2004  
32
Triggers of perioperative myocardial ischaemia and infarction.
[15096440] Br J Anaesth 93(1): 9-20 (2004)
2008  
33
Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
[18633035] Anesth Analg 107(2): 552-69 (2008)
2008  
34
Coronary artery stents: II. Perioperative considerations and management.
[18633036] Anesth Analg 107(2): 570-90 (2008)
2007  
35
Drug-eluting coronary stents: what are the risks?
[17457119] Anesthesiology 106(5): 898-900 (2007)
2010  
36
Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome?
[20078433] Acad Emerg Med 17(1): 1-10 (2010)
2002  
37
Bench to bedside: pathophysiology of acute coronary syndromes and implications for therapy.
[12359542] Acad Emerg Med 9(10): 1029-44 (2002)
2001  
38
Electrocardiographic ST-segment elevation: the diagnosis of acute myocardial infarction by morphologic analysis of the ST segment.
[11581081] Acad Emerg Med 8(10): 961-7 (2001)
2001  
39
ST-elevation acute myocardial infarction: a critical but difficult electrocardiographic diagnosis.
[11282674] Acad Emerg Med 8(4): 382-5 (2001)
2003  
40
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Diamorphine or morphine for ischaemic cardiac chest pain.
[12748145] Emerg Med J 20(3): 263-4 (2003)
2000  
41
Acute myocardial infarction in patients with left bundle branch block.
[10659001] J Accid Emerg Med 17(1): 74 (2000)
2004  
42
Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies.
[15448586] CNS Spectr 9(10): 763-72 (2004)
2007  
43
Coronary artery pathology.
[17934012] Heart 93(11): 1484-9 (2007)
2007  
44
Long term medical treatment of stable coronary disease.
[17934010] Heart 93(11): 1473-7 (2007)
2007  
45
ST elevation after myocardial infarction: what does it mean?
[17933986] Heart 93(11): 1329-30 (2007)
2007  
46
Vascular pathology as a result of drug-eluting stents.
[17639102] Heart 93(8): 895-6 (2007)
2007  
47
Treatment of stable angina.
[17569815] Heart 93(7): 868-74 (2007)
2007  
48
Alternative treatments for angina.
[17435065] Heart 93(5): 544-6 (2007)
2006  
49
Pathological changes in the coronary arteries in the acute coronary syndromes.
[17041107] Heart 92(11): 1557-8 (2006)
2006  
50
The pathology of myocardial infarction in the pre- and post-interventional era.
[16621872] Heart 92(11): 1552-6 (2006)
2006  
51
The future of drug eluting stents.
[16216857] Heart 92(5): 585-8 (2006)
2006  
52
Drug eluting stents: an updated meta-analysis of randomised controlled trials.
[16216853] Heart 92(5): 641-9 (2006)
2005  
53
Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.
[16103539] Heart 91(9): 1135-40 (2005)
2005  
54
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes.
[16103531] Heart 91(9): 1121-3 (2005)
2005  
55
The ECG in acute coronary syndromes: new tricks from an old dog.
[15958340] Heart 91(7): 851-3 (2005)
2004  
56
Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?
[15547007] Heart 90(12): 1379-83 (2004)
2004  
57
Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.
[15201238] Heart 90(7): 732-8 (2004)
2004  
58
The pathophysiology of myocardial ischaemia.
[15084567] Heart 90(5): 576-80 (2004)
2004  
59
Recent insights into human coronary collateral development.
[14966033] Heart 90(3): 246-50 (2004)
2004  
60
Chronic therapeutically refractory angina pectoris.
[14729809] Heart 90(2): 225-30 (2004)
2004  
61
Clinical implications of the new definition of myocardial infarction.
[14676259] Heart 90(1): 99-106 (2004)
2003  
62
The human coronary collateral circulation.
[14594903] Heart 89(11): 1352-7 (2003)
2003  
63
Carotid artery stenting.
[12860884] Heart 89(8): 944-8 (2003)
2003  
64
In-stent stenosis: pathology and implications for the development of drug eluting stents.
[12527687] Heart 89(2): 218-24 (2003)
2002  
65
Management of cardiogenic shock complicating acute myocardial infarction.
[12381652] Heart 88(5): 531-7 (2002)
2002  
66
Role of echocardiography in acute coronary syndromes.
[12231611] Heart 88(4): 419-25 (2002)
2002  
67
Acute myocardial infarction: reperfusion treatment.
[12181231] Heart 88(3): 298-305 (2002)
2000  
68
Coronary disease. Management of the post-myocardial infarction patient: rehabilitation and cardiac neurosis.
[10862600] Heart 84(1): 101-5 (2000)
2000  
69
Coronary disease. Acute coronary syndromes: presentation--clinical spectrum and management.
[10862599] Heart 84(1): 93-100 (2000)
2000  
70
The natural history of acute myocardial infarction.
[10814643] Heart 83(6): 726-30 (2000)
2000  
71
The pathophysiology of acute coronary syndromes.
[10677422] Heart 83(3): 361-6 (2000)
1999  
72
The radial approach for coronary angiography and stenting.
[10490550] Heart 82(4): 411-2 (1999)
1999  
73
The radial artery as a conduit for coronary artery bypass grafting.
[10490549] Heart 82(4): 409-10 (1999)
1999  
74
Pathogenic mechanisms in unstable angina.
[10469669] Heart 82 Suppl 1(-): I2-4 (1999)
1997  
75
Patients with suspected myocardial infarction presenting with ST segment depression.
[9227287] Heart 77(6): 493-4 (1997)
1996  
76
Inhibition of the renin-angiotensin system after acute myocardial infarction--treat first, select later?
[8977366] Heart 76(3 Suppl 3): 73-8 (1996)
1996  
77
Neuroendocrine activation after myocardial infarction: causes and consequences.
[8977365] Heart 76(3 Suppl 3): 53-9 (1996)
1996  
78
The renin-angiotensin system and the heart: a historical review.
[8977359] Heart 76(3 Suppl 3): 7-12 (1996)
1994  
79
What to expect from ACE inhibitors after myocardial infarction.
[7946808] Br Heart J 72(3 Suppl): S70-4 (1994)
1994  
80
Neuroendocrine activation after myocardial infarction.
[7946807] Br Heart J 72(3 Suppl): S65-9 (1994)
1994  
81
Effects of ACE inhibitors on coronary haemodynamics and angina pectoris.
[7946804] Br Heart J 72(3 Suppl): S52-6 (1994)
1994  
82
Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
[8130017] Br Heart J 71(2): 115-8 (1994)
1983  
83
Beta adrenoceptor antagonists after myocardial infarction--where are we now?
[6130777] Br Heart J 49(2): 105-10 (1983)
1970  
84
Exploring surgical treatment for myocardial infarction.
[4914820] Br Heart J 32(4): 421-6 (1970)
2008  
85
Pathophysiology of aortocoronary saphenous vein bypass graft disease.
[18670032] Asian Cardiovasc Thorac Ann 16(4): 331-6 (2008)
2008  
86
Current status of off-pump coronary artery bypass surgery.
[18381881] Asian Cardiovasc Thorac Ann 16(2): 164-78 (2008)
2007  
87
Post myocardial infarction left ventricular free wall rupture.
[17669764] Interact Cardiovasc Thorac Surg 6(1): 39-42 (2007)
2000  
88
Early initiation of ACE inhibitor treatment after acute myocardial infarction--a missed therapeutic opportunity?
[11881032] J Renin Angiotensin Aldosterone Syst 1(3): 245-51 (2000)
2008  
89
Spontaneous coronary artery dissection: current insights and therapy.
[18958258] Neth Heart J 16(10): 344-9 (2008)
2007  
90
Posterior myocardial infarction: the dark side of the moon.
[17612703] Neth Heart J 15(1): 16-21 (2007)
2009  
91
Recent insights into the mechanisms of vasospastic angina.
[20049135] Korean Circ J 39(12): 505-11 (2009)
2009  
92
Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?
[20031694] Circ Cardiovasc Interv 2(1): 59-68 (2009)
2009  
93
Coronary vein graft disease: pathogenesis and prevention.
[19214303] Can J Cardiol 25(2): e57-62 (2009)
2009  
94
Therapeutic options in coronary artery disease: focusing on the guidelines.
[19148338] Can J Cardiol 25(1): 19-24 (2009)
2007  
95
Timing of bypass surgery in stable patients after acute myocardial infarction.
[17932574] Can J Cardiol 23(12): 976-82 (2007)
1999  
96
Current status of transmyocardial laser revascularization: review of the literature.
[10202194] Can J Cardiol 15(3): 303-10 (1999)
1997  
97
Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.
[9070169] Can J Cardiol 13(2): 173-82 (1997)
2007  
98
Clinical use of sirolimus-eluting stents.
[18078432] Cardiovasc Drug Rev 25(4): 316-32 (2007)
2006  
99
Role of adenosine as adjunctive therapy in acute myocardial infarction.
[16961725] Cardiovasc Drug Rev 24(2): 116-47 (2006)
2006  
100
Oxidative stress as the leading cause of acute myocardial infarction in diabetics.
[16961722] Cardiovasc Drug Rev 24(2): 77-87 (2006)
2007  
101
Silent myocardial ischemia: Current perspectives and future directions.
[18651003] Exp Clin Cardiol 12(4): 189-96 (2007)
2009  
102
Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials.
[19320999] BMC Cardiovasc Disord 9(-): 13 (2009)
2010  
103
Stent thrombosis--risk assessment and prevention.
[20553282] Cardiovasc Ther 28(5): e92-100 (2010)
2010  
104
The 'chest pain kit' study: A 'pill in the pocket' concept to improve the pre-hospital therapy of acute coronary syndrome.
[20865688] Cardiol J 17(5): 528-31 (2010)
2010  
105
Testosterone levels: key to survival after myocardial infarction?
[20535710] Cardiol J 17(3): 217-8 (2010)
2008  
106
In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
[18810721] Cardiol J 15(5): 451-7 (2008)
2008  
107
Hyperglycemia as a risk factor in postinfarction patients.
[18810713] Cardiol J 15(5): 399-401 (2008)
2008  
108
Allergic myocardial infarction.
[18651413] Cardiol J 15(3): 220-5 (2008)
2008  
109
Bioabsorbable coronary stents.
[19039765] Cardiol J 15(6): 569-71 (2008)
2009  
110
Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction.
[19901420] J Invasive Cardiol 21(11): E206-12 (2009)
2009  
111
Unique challenges of full metal jackets in the era of drug-eluting stents.
[19182290] J Invasive Cardiol 21(2): 51-2 (2009)
2008  
112
Very late thrombosis of drug-eluting stents: a brief literature review and case example.
[19057030] J Invasive Cardiol 20(12): 655-8 (2008)
2008  
113
Spontaneous coronary artery dissection: case series and review.
[18830003] J Invasive Cardiol 20(10): 553-9 (2008)
2008  
114
A universal classification system for chronic total occlusions.
[18523325] J Invasive Cardiol 20(6): 302-4 (2008)
2008  
115
Protection devices and thrombectomy for native coronary artery ST-elevation myocardial infarction.
[18398237] J Invasive Cardiol 20(4): 190-5 (2008)
2008  
116
Bifurcation coronary artery disease: current techniques and future directions (part 2).
[18316830] J Invasive Cardiol 20(3): 135-41 (2008)
2008  
117
Bifurcation coronary artery disease: current techniques and future directions (part 1).
[18252973] J Invasive Cardiol 20(2): 82-90 (2008)
2007  
118
Multivessel PCI versus CABG: one-year outcomes and cost analysis.
[17986723] J Invasive Cardiol 19(11): 476-7 (2007)
2007  
119
Extended stenting of distal left main coronary artery for the treatment of branch ostial disease -- belling the cat or bearding the lion!
[17986720] J Invasive Cardiol 19(11): 462-3 (2007)
2006  
120
Blunt microdissection and rotational atherectomy: an effective combination for the resistant chronic total occlusion.
[16954592] J Invasive Cardiol 18(9): E246-9 (2006)
2006  
121
Percutaneous coronary intervention in the elderly patient (Part II of II).
[16783889] J Invasive Cardiol 18(6): 286-95 (2006)
2006  
122
Percutaneous coronary intervention in the elderly patient (Part I of II).
[16775902] J Invasive Cardiol 18(6): 286-95 (2006)
2006  
123
Cardiogenic shock due to complete thrombotic occlusion of the left main coronary ostium in a young female.
[16775891] J Invasive Cardiol 18(6): E188-90 (2006)
2006  
124
Pronto catheter thrombectomy in acute ST-segment myocardial infarction: a case series.
[16775871] J Invasive Cardiol 18(6): E191-4 (2006)
2005  
125
Rescue percutaneous coronary intervention: a review.
[16264215] J Invasive Cardiol 17(11): 620-5 (2005)
2004  
126
Spontaneous coronary artery dissection: management options in the stent era.
[15156006] J Invasive Cardiol 16(6): 333-5 (2004)
2003  
127
Contemporary view of the acute coronary syndromes.
[12556619] J Invasive Cardiol 15(2): 71-9 (2003)
2002  
128
Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.
[12205361] J Invasive Cardiol 14(9): 565-74 (2002)
2002  
129
Myocardial infarction and the culprit plaque: myths, data and statistics.
[12042631] J Invasive Cardiol 14(6): 347-52 (2002)
2002  
130
Part II: risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review.
[11983947] J Invasive Cardiol 14(5): 254-62 (2002)
2002  
131
Risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review.
[11923580] J Invasive Cardiol 14(4): 215-20 (2002)
2002  
132
New techniques for the evaluation of the vulnerable plaque.
[11870268] J Invasive Cardiol 14(3): 129-37 (2002)
2001  
133
Chronic total occlusion: view the challenge.
[11146678] J Invasive Cardiol 13(1): 9-11 (2001)
2009  
134
Choice of conduits for coronary artery bypass grafting: craft or science?
[19231230] Eur J Cardiothorac Surg 35(4): 658-70 (2009)
2006  
135
Status of percutaneous coronary intervention and coronary artery bypass.
[16857370] Eur J Cardiothorac Surg 30(3): 419-24 (2006)
2006  
136
The fate of the radial artery conduit in coronary artery bypass grafting surgery.
[16829081] Eur J Cardiothorac Surg 30(2): 341-6 (2006)
2003  
137
Off-pump coronary artery bypass grafting: the myth, the logic and the science.
[14500075] Eur J Cardiothorac Surg 24(4): 557-70 (2003)
2002  
138
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.
[11825729] Eur J Cardiothorac Surg 21(2): 232-44 (2002)
2000  
139
Transabdominal mimially invasive direct coronary artery bypass grafting (MIDCAB).
[10773575] Eur J Cardiothorac Surg 17(4): 485-7 (2000)
1997  
140
Left main coronary artery atresia: literature review and therapeutical considerations.
[9105816] Eur J Cardiothorac Surg 11(3): 505-14 (1997)
2010  
141
Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.
[20407625] Vasc Health Risk Manag 6(-): 179-87 (2010)
2009  
142
Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.
[20057901] Vasc Health Risk Manag 5(-): 1089-97 (2009)
2009  
143
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
[19997577] Vasc Health Risk Manag 5(-): 965-72 (2009)
2009  
144
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
[19898643] Vasc Health Risk Manag 5(-): 873-82 (2009)
2009  
145
Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.
[19707287] Vasc Health Risk Manag 5(-): 677-91 (2009)
2009  
146
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.
[19475783] Vasc Health Risk Manag 5(1): 475-81 (2009)
2009  
147
Prasugrel for the treatment of patients with acute coronary syndrome.
[19436677] Vasc Health Risk Manag 5(1): 321-4 (2009)
2009  
148
Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention.
[19436675] Vasc Health Risk Manag 5(1): 275-86 (2009)
2009  
149
Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data.
[19436647] Vasc Health Risk Manag 5(1): 243-7 (2009)
2008  
150
Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin.
[18827868] Vasc Health Risk Manag 4(3): 493-505 (2008)
2008  
151
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).
[18629361] Vasc Health Risk Manag 4(1): 31-8 (2008)
2008  
152
Regadenoson in the detection of coronary artery disease.
[18561509] Vasc Health Risk Manag 4(2): 337-40 (2008)
2007  
153
Drug eluting stents: focus on Cypher sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions.
[17969375] Vasc Health Risk Manag 3(4): 441-51 (2007)
2007  
154
Management of acute coronary syndromes with fondaparinux.
[17703640] Vasc Health Risk Manag 3(3): 321-9 (2007)
2006  
155
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).
[17323592] Vasc Health Risk Manag 2(4): 379-87 (2006)
2006  
156
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.
[17323591] Vasc Health Risk Manag 2(4): 371-8 (2006)
2006  
157
Bivalirudin in percutaneous coronary intervention.
[17323589] Vasc Health Risk Manag 2(4): 357-63 (2006)
2007  
158
Sirolimus-eluting coronary stents: a review.
[17580729] Vasc Health Risk Manag 3(2): 191-201 (2007)
2005  
159
Drug-eluting stent: a review and update.
[17315599] Vasc Health Risk Manag 1(4): 263-76 (2005)
2008  
160
Thrombopoietin emerges as a new haematopoietic cytokine that confers cardioprotection against acute myocardial infarction.
[18006435] Cardiovasc Res 77(1): 2-3 (2008)
2006  
161
ACE inhibitors and statins for bone marrow failure following myocardial infarction?
[16515775] Cardiovasc Res 70(1): 1-2 (2006)
2004  
162
Biological aspects of radiation and drug-eluting stents for the prevention of restenosis.
[15194458] Cardiovasc Res 63(1): 22-30 (2004)
2001  
163
The role of altered intercellular coupling in arrhythmias induced by acute myocardial ischemia.
[11334830] Cardiovasc Res 50(2): 263-9 (2001)
2001  
164
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications.
[11166268] Cardiovasc Res 49(3): 554-60 (2001)
2000  
165
ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia.
[10728321] Cardiovasc Res 45(1): 111-8 (2000)
1999  
166
The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions.
[10690298] Cardiovasc Res 44(2): 232-41 (1999)
1999  
167
Are the arrhythmias due to myocardial ischaemia and infarction dependent upon the sympathetic system?
[10615408] Cardiovasc Res 43(4): 830-1 (1999)
1999  
168
Electrical remodeling in ischemia and infarction.
[10533567] Cardiovasc Res 42(2): 284-97 (1999)
1999  
169
Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin.
[10341841] Cardiovasc Res 41(2): 418-32 (1999)
1999  
170
Strategies to achieve coronary arterial plaque stabilization.
[10341840] Cardiovasc Res 41(2): 402-17 (1999)
1998  
171
Animal models in the study of myocardial ischaemia and ischaemic syndromes.
[9764194] Cardiovasc Res 39(1): 121-35 (1998)
1996  
172
Mechanisms and prevention of restenosis: from experimental models to clinical practice.
[8759238] Cardiovasc Res 31(6): 835-46 (1996)
2006  
173
A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.
[16722835] Br J Clin Pharmacol 61(6): 720-6 (2006)
2000  
174
Histamine H(3)-receptors: a new frontier in myocardial ischemia.
[10688593] J Pharmacol Exp Ther 292(3): 825-30 (2000)
2007  
175
Drug-eluting stents: a systematic review and economic evaluation.
[17999841] Health Technol Assess 11(46): iii, xi-221 (2007)
2005  
176
Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.
[15876363] Health Technol Assess 9(17): 1-99, iii-iv (2005)
2004  
177
Coronary artery stents: a rapid systematic review and economic evaluation.
[15361315] Health Technol Assess 8(35): iii-iv, 1-242 (2004)
2000  
178
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
[11074393] Health Technol Assess 4(23): 1-153 (2000)
2010  
179
Eptifibatide: The evidence for its role in the management of acute coronary syndromes.
[20694065] Core Evid 4(-): 49-65 (2010)
2009  
180
An overview of glycemic control in the coronary care unit with recommendations for clinical management.
[20144388] J Diabetes Sci Technol 3(6): 1342-51 (2009)
2009  
181
Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction.
[20130773] Int J Cell Biol 2009(-): 904682 (2009)
2009  
182
Cellular therapy for repair of cardiac damage after acute myocardial infarction.
[20130765] Int J Cell Biol 2009(-): 906507 (2009)
2007  
183
Antiphospholipid antibodies in young myocardial infarction patients.
[18320848] Indian J Biochem Biophys 44(6): 481-4 (2007)
2009  
184
Does timing of dialysis in patients with ESRD and acute myocardial infarcts affect morbidity or mortality?
[19590061] Clin J Am Soc Nephrol 4(8): 1324-30 (2009)
2009  
185
Optimal method of coronary revascularization in patients receiving dialysis: systematic review.
[19218473] Clin J Am Soc Nephrol 4(2): 369-78 (2009)
2009  
186
Coronary calcification in chronic kidney disease: morphology, mechanisms and mortality.
[19965543] Clin J Am Soc Nephrol 4(12): 1883-5 (2009)
1991  
187
Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years.
[2025057] Ann Surg 213(5): 377-85; discussion 386-7 (1991)
2006  
188
[Role of the vascular wall in the pathophysiology of the acute coronary syndrome].
[16676055] Hamostaseologie 26(2): 123-30 (2006)
2006  
189
[Pathophysiology of acute coronary syndrome].
[16676050] Hamostaseologie 26(2): 99-103 (2006)
2006  
190
[Antithrombotic therapy for non-ST segment elevation myocardial infarction].
[16676052] Hamostaseologie 26(2): 106-13 (2006)
2006  
191
[The role of platelets for the pathophysiology of acute coronary syndromes].
[16676053] Hamostaseologie 26(2): 114-8 (2006)
2006  
192
[Platelet inhibitors from a cardiological viewpoint: evidence based therapy and new concepts for the acute coronary syndrome without ST-segment elevation].
[16676054] Hamostaseologie 26(2): 119-22 (2006)
2009  
193
The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction.
[19090814] J Thromb Haemost 7(1): 14-20 (2009)
2000  
194
Coronary artery stents: review and patient-management recommendations.
[10860332] J Am Dent Assoc 131(6): 797-801 (2000)
2008  
195
The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies.
[18346962] Eur Heart J 29(8): 1057-71 (2008)
2008  
196
Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?
[18245118] Eur Heart J 29(3): 299-314 (2008)
2008  
197
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology.
[17971402] Eur Heart J 29(2): 277-8 (2008)
2007  
198
Use of the electrocardiogram in optimizing reperfusion for ST-elevation myocardial infarction: a new role for an old tool?
[18006542] Eur Heart J 28(24): 2957-9 (2007)
2007  
199
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.
[17901079] Eur Heart J 28(22): 2706-13 (2007)
2007  
200
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
[17600038] Eur Heart J 28(17): 2077-86 (2007)
2007  
201
Link between erythropoietin release and mobilization of endothelial progenitor cells in acute myocardial infarction.
[17606470] Eur Heart J 28(15): 1785-6 (2007)
2007  
202
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.
[17569677] Eur Heart J 28(13): 1598-660 (2007)
2007  
203
Recurrent angina after coronary revascularization: a clinical challenge.
[17384090] Eur Heart J 28(9): 1057-65 (2007)
2007  
204
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
[17347176] Eur Heart J 28(7): 788-97 (2007)
2007  
205
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
[17267457] Eur Heart J 28(4): 433-42 (2007)
2007  
206
Importance of collateral circulation in coronary heart disease.
[17218452] Eur Heart J 28(3): 278-91 (2007)
2006  
207
Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire?
[17107977] Eur Heart J 27(23): 2737-9 (2006)
2006  
208
Cause of death with bare metal and sirolimus-eluting stents.
[17107976] Eur Heart J 27(23): 2815-22 (2006)
2006  
209
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
[17020889] Eur Heart J 27(23): 2784-814 (2006)
2006  
210
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.
[17053008] Eur Heart J 27(22): 2667-74 (2006)
2006  
211
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.
[16735367] Eur Heart J 27(11): 1341-81 (2006)
2006  
212
Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.
[16513663] Eur Heart J 27(7): 779-88 (2006)
2006  
213
Long-term anticoagulant therapy in patients with coronary artery disease.
[16401675] Eur Heart J 27(8): 913-9 (2006)
2005  
214
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
[16055497] Eur Heart J 26(19): 2063-74 (2005)
2005  
215
Timing of arrhythmic death after myocardial infarction: does it affect timing of ICD implantation?
[15872027] Eur Heart J 26(14): 1350-2 (2005)
2005  
216
The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina.
[15716284] Eur Heart J 26(10): 1011-22 (2005)
2005  
217
Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials.
[15681573] Eur Heart J 26(9): 881-9 (2005)
2005  
218
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era.
[15778204] Eur Heart J 26(8): 762-9 (2005)
2005  
219
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
[15769784] Eur Heart J 26(8): 804-47 (2005)
2004  
220
Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefit.
[15451141] Eur Heart J 25(19): 1667-9 (2004)
2004  
221
Drug-eluting stents: an early systematic review to inform policy.
[15172462] Eur Heart J 25(11): 902-19 (2004)
2004  
222
Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation.
[15172459] Eur Heart J 25(11): 895-7 (2004)
2003  
223
Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques.
[12590904] Eur Heart J 24(3): 266-73 (2003)
2003  
224
A meta-analytical approach for the treatment of in-stent restenosis.
[12590898] Eur Heart J 24(3): 217-8 (2003)
2003  
225
The challenge of in-stent restenosis: insights from intravascular ultrasound.
[12573271] Eur Heart J 24(2): 138-50 (2003)
2003  
226
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
[12559937] Eur Heart J 24(1): 28-66 (2003)
2001  
227
Residual myocardial ischaemia as a contributor to electrical instability after myocardial infarction.
[11601832] Eur Heart J 22(20): 1845-6 (2001)
2001  
228
Multivessel coronary artery disease: current revascularization strategies.
[11440491] Eur Heart J 22(14): 1183-97 (2001)
2001  
229
The Q wave infarct; phenomenon or chimera?
[11428830] Eur Heart J 22(12): 980-2 (2001)
2001  
230
Intracoronary radiation therapy.
[11286520] Eur Heart J 22(8): 629-47 (2001)
2000  
231
The management of refractory angina.
[11071793] Eur Heart J 21(23): 1909-10 (2000)
2000  
232
Coronary in-stent restenosis - predictors, treatment and prevention.
[11052838] Eur Heart J 21(21): 1739-49 (2000)
2000  
233
Rotational atherectomy revisited in the era of stenting.
[11052832] Eur Heart J 21(21): 1727-9 (2000)
2003  
234
Basic aspects of plaque vulnerability.
[12975444] Heart 89(10): 1262-7 (2003)
2003  
235
Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis.
[12807853] Heart 89(7): 767-72 (2003)
2001  
236
Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system.
[11602533] Heart 86(5): 485-6 (2001)
2001  
237
The patient with acute myocardial infarction who does not receive reperfusion treatment.
[11514468] Heart 86(3): 243-5 (2001)
2000  
238
Percutaneous myocardial laser revascularisation.
[10677396] Heart 83(3): 253-4 (2000)
2000  
239
Neurostimulation treatment for angina pectoris.
[10648501] Heart 83(2): 217-20 (2000)
1996  
240
Transmyocardial revascularisation.
[8868972] Heart 76(3): 191-2 (1996)
1996  
241
Intravascular radiation for restenosis prevention: could it be the holy grail?
[8795465] Heart 76(2): 99-100 (1996)
2006  
242
Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.
[16861690] Am J Physiol Heart Circ Physiol 291(6): H2570-82 (2006)
2005  
243
2001  
244
Reperfusion arrhythmias and sudden cardiac death: a century of progress toward an understanding of the mechanisms.
[11679400] Circ Res 89(9): 741-3 (2001)
1981  
245
Hormonal and metabolic reactions evoked by acute myocardial infarction.
[7014018] Circ Res 48(6 Pt 1): 767-76 (1981)
1978  
246
Autonomic neural influences on the dysrhythmias resulting from myocardial infarction.
[350450] Circ Res 43(1): 1-9 (1978)
1978  
247
Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction.
[350449] Circ Res 42(6): 740-9 (1978)
2007  
248
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
[17679616] Circulation 116(7): e148-304 (2007)
2007  
249
Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence.
[17664378] Circulation 116(5): e110-3 (2007)
2007  
250
Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same?
[17638940] Circulation 116(3): 316-28 (2007)
2007  
251
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures).
[17592076] Circulation 116(1): 98-124 (2007)
2007  
252
Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction.
[17485582] Circulation 115(18): e436-9 (2007)
2006  
253
Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies.
[16740920] Heart 92(11): 1588-94 (2006)
2006  
254
Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry.
[16644860] Heart 92(11): 1571-6 (2006)
2006  
255
The pathophysiology of myocardial reperfusion: a pathologist's perspective.
[16547203] Heart 92(11): 1559-62 (2006)
2006  
256
Aspiration thrombectomy and primary percutaneous coronary intervention.
[16670099] Heart 92(7): 867-9 (2006)
2004  
257
Pathologic assessment of the vulnerable human coronary plaque.
[15547008] Heart 90(12): 1385-91 (2004)
2004  
258
Renal dysfunction and acceleration of coronary disease.
[15253986] Heart 90(8): 961-6 (2004)
2004  
259
Percutaneous coronary intervention for bifurcation coronary disease.
[15145893] Heart 90(6): 713-22 (2004)
2003  
260
Plaque stabilisation in acute coronary syndromes: clinical considerations.
[12975445] Heart 89(10): 1268-72 (2003)
2000  
261
Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models.
[10651199] Jpn Circ J 64(1): 1-12 (2000)
2000  
262
Irradiation and postangioplasty restenosis: a recent overview.
[11132163] Jpn Heart J 41(5): 541-70 (2000)
2005  
263
Successful use of sirolimus-eluting stents for treatment of ST-elevation acute myocardial infarction caused by left main coronary artery occlusion.
[16392234] Tex Heart Inst J 32(3): 421-3 (2005)
1998  
264
Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease?
[9566059] Tex Heart Inst J 25(1): 24-9 (1998)
1984  
265
Coronary thrombolysis with tissue-type plasminogen activator: prospective review.
[15226873] Tex Heart Inst J 11(4): 344-7 (1984)
1999  
266
Intracoronary artery radiation.
[10700816] Br J Radiol 72(863): 1033-6 (1999)
1991  
267
The evaluation of coronary bypass graft patency: direct and indirect techniques other than coronary arteriography.
[1898551] AJR Am J Roentgenol 156(1): 15-22 (1991)
1982  
268
Garland lecture. Coronary arteriography: pathologic and prognostic implications.
[7046401] AJR Am J Roentgenol 139(1): 1-18 (1982)
2009  
269
The Enhancing Secondary Prevention in Coronary Artery Disease trial.
[19933787] CMAJ 181(12): 897-904 (2009)
2009  
270
Are drug-eluting stents safe in the long term?
[19106153] CMAJ 180(2): 154-5 (2009)
2007  
271
The cost-effectiveness of drug-eluting stents: a systematic review.
[17179219] CMAJ 176(2): 199-205 (2007)
2007  
272
Drug-eluting coronary stents: faith and hope, but no charity.
[17179218] CMAJ 176(2): 195-6 (2007)
2006  
273
Revascularization in patients with heart failure.
[16908896] CMAJ 175(4): 361-5 (2006)
2006  
274
New imaging techniques for diagnosing coronary artery disease.
[16477061] CMAJ 174(4): 487-95 (2006)
2005  
275
Immediate angioplasty after thrombolysis: a systematic review.
[16330637] CMAJ 173(12): 1473-81 (2005)
2002  
276
New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
[11949991] CMAJ 166(7): 919-24 (2002)
2002  
277
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures.
[11800249] CMAJ 166(1): 51-9 (2002)
2001  
278
New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.
[11584571] CMAJ 165(6): 791-7 (2001)
1988  
279
Acute non-Q-wave myocardial infarction: a distinct clinical entity of increasing importance.
[3044553] CMAJ 139(6): 487-93 (1988)
2002  
280
2002  
281
Pathophysiology and management of right heart ischemia.
[12225706] J Am Coll Cardiol 40(5): 841-53 (2002)
2002  
282
Refractory angina pectoris: mechanism and therapeutic options.
[11897431] J Am Coll Cardiol 39(6): 923-34 (2002)
2001  
283
ST segment resolution as a tool for assessing the efficacy of reperfusion therapy.
[11691496] J Am Coll Cardiol 38(5): 1283-94 (2001)
2000  
284
First line drugs in chronic stable effort angina--the case for newer, longer-acting calcium channel blocking agents.
[11092672] J Am Coll Cardiol 36(6): 1967-71 (2000)
2000  
285
A union in reperfusion: the concept of facilitated percutaneous coronary intervention.
[11079648] J Am Coll Cardiol 36(5): 1497-9 (2000)
2000  
286
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
[10987628] J Am Coll Cardiol 36(3): 959-69 (2000)
1999  
287
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina).
[10362225] J Am Coll Cardiol 33(7): 2092-197 (1999)
1998  
288
Coronary interventions at a crossroads: the bifurcation stenosis.
[9857862] J Am Coll Cardiol 32(7): 1853-4 (1998)
1998  
289
Treatment of right ventricular infarction: thrombolytic therapy, coronary angioplasty or neither?
[9768706] J Am Coll Cardiol 32(4): 882-4 (1998)
1998  
290
Heparin for acute myocardial infarction: the controversy continues.
[9561994] J Am Coll Cardiol 31(5): 964-6 (1998)
1998  
291
Myonecrosis after revascularization procedures.
[9462562] J Am Coll Cardiol 31(2): 241-51 (1998)
2008  
292
Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction.
[19106394] Circulation 118(25): 2710-8 (2008)
2008  
293
Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?
[19001032] Circulation 118(20): 2019-21 (2008)
2008  
294
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
[18852370] Circulation 118(18): 1828-36 (2008)
2008  
295
The emerging role of thrombus aspiration in the management of acute myocardial infarction.
[18852361] Circulation 118(18): 1780-2 (2008)
2008  
296
Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
[18725490] Circulation 118(11): 1146-54 (2008)
2008  
297
What do you need to know before performing a percutaneous coronary intervention?
[18678781] Circulation 118(6): 609-11 (2008)
2008  
298
Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction.
[18663104] Circulation 118(5): 567-73 (2008)
2008  
299
Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions.
[18663103] Circulation 118(5): 552-66 (2008)
2008  
300
Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention.
[18663102] Circulation 118(5): 538-51 (2008)
2008  
301
Stents or surgery? New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery.
[18645064] Circulation 118(4): 325-7 (2008)
2008  
302
Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia.
[18443246] Circulation 117(17): 2172-7 (2008)
2008  
303
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.
[18079354] Circulation 117(2): 261-95 (2008)
2008  
304
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.
[18071078] Circulation 117(2): 296-329 (2008)
2007  
305
2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
[17998462] Circulation 116(23): 2762-72 (2007)
2007  
306
Universal definition of myocardial infarction.
[17951284] Circulation 116(22): 2634-53 (2007)
2007  
307
Late coronary stent thrombosis.
[17965406] Circulation 116(17): 1952-65 (2007)
2007  
308
Neurocognitive changes after coronary bypass surgery.
[17965403] Circulation 116(17): 1879-81 (2007)
2007  
309
Acute noncardiac conditions and in-hospital mortality in patients with acute myocardial infarction.
[17923572] Circulation 116(17): 1925-30 (2007)
2007  
310
Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
[17875983] Circulation 116(12): 1424-32 (2007)
2007  
311
Drug-eluting stent update 2007: part II: Unsettled issues.
[17709651] Circulation 116(8): 961-8 (2007)
2007  
312
Drug-eluting stents: dual antiplatelet therapy for every survivor?
[17698743] Circulation 116(7): 696-9 (2007)
2007  
313
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
[17502591] Circulation 115(19): 2570-89 (2007)
2007  
314
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
[17502590] Circulation 115(19): 2549-69 (2007)
2007  
315
Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
[17485594] Circulation 115(18): 2451-7 (2007)
2007  
316
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
[17384331] Circulation 115(13): e356-75 (2007)
2007  
317
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
[17224480] Circulation 115(6): 813-8 (2007)
2006  
318
Drug-eluting stents: the price is not right.
[17043178] Circulation 114(16): 1745-54; discussion 1754 (2006)
2006  
319
Are drug-eluting stents cost-effective? It depends on whom you ask.
[17043177] Circulation 114(16): 1736-43; discussion 1744 (2006)
2006  
320
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).
[16490830] Circulation 113(7): e166-286 (2006)
2006  
321
Physiological basis of clinically used coronary hemodynamic indices.
[16432075] Circulation 113(3): 446-55 (2006)
2006  
322
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
[16391169] Circulation 113(1): 156-75 (2006)
2005  
323
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
[16344381] Circulation 112(25): 3855-67 (2005)
2005  
324
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
[16230504] Circulation 112(16): 2530-7 (2005)
2005  
325
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
[16216980] Circulation 112(15): 2364-72 (2005)
2005  
326
Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction.
[16203924] Circulation 112(14): 2085-8 (2005)
2005  
327
Pathophysiology of coronary artery disease.
[15983262] Circulation 111(25): 3481-8 (2005)
2005  
328
Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
[15927966] Circulation 111(22): 2906-12 (2005)
2005  
329
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers.
[15911720] Circulation 111(20): 2699-710 (2005)
2005  
330
Molecular basis of restenosis and drug-eluting stents.
[15867193] Circulation 111(17): 2257-73 (2005)
2005  
331
New frontiers in interventional cardiology.
[15699286] Circulation 111(5): 671-81 (2005)
2004  
332
Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion.
[15611375] Circulation 110(25): e533-9 (2004)
2004  
333
Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction.
[15557381] Circulation 110(21): e506-10 (2004)
2004  
334
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).
[15339869] Circulation 110(9): e82-292 (2004)
2004  
335
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
[15339866] Circulation 110(9): 1168-76 (2004)
2004  
336
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
[15289388] Circulation 110(5): 588-636 (2004)
2004  
337
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
[14769687] Circulation 109(5): 641-6 (2004)
2003  
338
2003  
339
Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator.
[12600904] Circulation 107(7): 941-6 (2003)
2000  
340
I like the candy, I hate the wrapper: the (32)P radioactive stent.
[10618295] Circulation 101(1): 3-7 (2000)
2000  
341
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
[10973764] Eur Heart J 21(18): 1502-13 (2000)
2000  
342
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.
[10952834] Eur Heart J 21(17): 1406-32 (2000)
2000  
343
Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
[10843815] Eur Heart J 21(13): 1029-31 (2000)
1999  
344
Methods for evaluating coronary microvasculature in humans.
[10462464] Eur Heart J 20(18): 1300-13 (1999)
1999  
345
Myocardial laser revascularization.
[10454968] Eur Heart J 20(17): 1213-4 (1999)
1998  
346
Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology.
[9519314] Eur Heart J 19(2): 207-29 (1998)
1997  
347
Intravascular radiation therapy in atherosclerotic disease: promises and premises.
[9458443] Eur Heart J 18(9): 1385-95 (1997)
1997  
348
Reconstruction and quantification with three-dimensional intracoronary ultrasound. An update on techniques, challenges, and future directions.
[9243137] Eur Heart J 18(7): 1056-67 (1997)
1997  
349
Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology.
[9076376] Eur Heart J 18(3): 394-413 (1997)
1996  
350
Angina with normal coronary arteries: diagnosis, pathophysiology and treatment.
[8960450] Eur Heart J 17 Suppl G(-): 14-9 (1996)
1996  
351
Secondary preventive potential of nitrates in ischaemic heart disease.
[8960445] Eur Heart J 17 Suppl F(-): 30-6 (1996)
1996  
352
Treatment for acute myocardial infarction. Overview of randomized clinical trials.
[8960444] Eur Heart J 17 Suppl F(-): 16-29 (1996)
1996  
353
The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.
[8960443] Eur Heart J 17 Suppl F(-): 9-15 (1996)
1996  
354
The rationale for thrombolytic therapy.
[11823999] Eur Heart J 17 Suppl E(-): 2-8 (1996)
2007  
355
Vascular responses to drug eluting stents: importance of delayed healing.
[17510464] Arterioscler Thromb Vasc Biol 27(7): 1500-10 (2007)
2007  
356
Biomarkers of atherosclerotic plaque instability and rupture.
[17082488] Arterioscler Thromb Vasc Biol 27(1): 15-26 (2007)
2000  
357
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.
[10807742] Arterioscler Thromb Vasc Biol 20(5): 1262-75 (2000)
2009  
358
Drug-eluting stents. Insights from invasive imaging technologies.
[19574723] Circ J 73(8): 1371-80 (2009)
2009  
359
Radial artery as a graft for coronary artery bypass grafting.
[19506319] Circ J 73(7): 1178-83 (2009)
2009  
360
Silent myocardial ischemia.
[19282605] Circ J 73(5): 785-97 (2009)
2009  
361
Molecular basis of restenosis and novel issues of drug-eluting stents.
[19282604] Circ J 73(4): 615-21 (2009)
2008  
362
The time has come for new, more precise guidelines in the treatment of high-risk acute coronary syndromes with heparin.
[18758089] Circ J 72(10): 1674-9 (2008)
2008  
363
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
[19004841] Eur Heart J 29(23): 2909-45 (2008)
2008  
364
Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly.
[18952611] Eur Heart J 29(24): 2953-4 (2008)
2008  
365
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
[18775918] Eur Heart J 29(24): 3002-10 (2008)
2008  
366
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.
[18523058] Eur Heart J 29(15): 1807-18 (2008)
2008  
367
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
[18519426] Eur Heart J 29(15): 1827-33 (2008)
2008  
368
Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.
[18346963] Eur Heart J 29(8): 1001-10 (2008)
1965  
369
ISCHEMIC HEART DISEASE: USE OF SERUM ENZYME DETERMINATIONS IN DIAGNOSIS.
[14336787] Calif Med 103(-): 21-6 (1965)
1967  
370
Coronary thrombosis and myocardial infarction.
[4863012] Can Med Assoc J 97(22): 1339-44 (1967)
2008  
371
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574278] Chest 133(6 Suppl): 776S-814S (2008)
2008  
372
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574276] Chest 133(6 Suppl): 670S-707S (2008)
2005  
373
A pictorial review of coronary artery bypass grafts at multidetector row CT.
[15821218] Chest 127(4): 1371-7 (2005)
2004  
374
Invasive management of patients with ST elevation myocardial infarction with > 12-h delay in presentation: the question remains unanswered.
[15249431] Chest 126(1): 2-4 (2004)
2002  
375
ECG discrimination between right and left circumflex coronary arterial occlusion in patients with acute inferior myocardial infarction: value of old criteria and use of lead aVR.
[12114348] Chest 122(1): 134-9 (2002)
1997  
376
A consensus approach to diagnosing coronary artery disease based on clinical and exercise test data.
[9187202] Chest 111(6): 1742-9 (1997)
1992  
377
The diagnosis of acute myocardial infarction.
[1555476] Chest 101(4 Suppl): 106S-115S (1992)
1990  
378
Thrombolytic therapy in acute myocardial infarction.
[2108851] Chest 97(4 Suppl): 136S-145S (1990)
1987  
379
On the pathogenesis of unstable angina.
[3652742] Chest 92(4): 581-2 (1987)
1982  
380
Unstable angina: a perspective.
[6126319] Chest 82(4): 466-72 (1982)
1981  
381
Risks in diagnosis and therapy of left main coronary atherosclerosis.
[7226901] Chest 79(4): 386-7 (1981)
1978  
382
ST-segment elevation during recovery from exercise. A new manifestation of Prinzmetal's variant angina.
[679740] Chest 74(2): 133-8 (1978)
1977  
383
Aortocoronary bypass surgery. Emerging triumph of controlled clinical trials.
[319961] Chest 71(3): 318-9 (1977)
1976  
384
Treatment of severe coronary artery disease with quadruple and quintuple saphenous vein grafts. Review of 100 consecutive patients.
[1081446] Chest 69(1): 29-32 (1976)
1970  
385
The delivery and distribution of coronary collateral circulation.
[4917905] Chest 58(3): 183-203 (1970)
2000  
386
Silent myocardial ischemia: an update.
[11344756] Isr Med Assoc J 2(11): 848-52 (2000)
2006  
387
Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults.
[16534169] J Postgrad Med 52(1): 51-6 (2006)
2003  
388
Drug-eluting intra-coronary stents: have we got the magic bullet?
[14597805] J Postgrad Med 49(3): 291-6 (2003)
2008  
389
Survival benefit with concomitant oral platelet therapy after coronary angiography and before ad hoc percutaneous coronary intervention.
[18775195] Mayo Clin Proc 83(9): 978-9 (2008)
2008  
390
Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease.
[18613996] Mayo Clin Proc 83(7): 799-805 (2008)
2006  
391
Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy.
[16706262] Mayo Clin Proc 81(5): 641-52 (2006)
2004  
392
Current and future treatment strategies for refractory angina.
[15473411] Mayo Clin Proc 79(10): 1284-92 (2004)
2002  
393
Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
[12374252] Mayo Clin Proc 77(10): 1085-92 (2002)
2002  
394
Current results and new developments of coronary angiography with use of contrast-enhanced computed tomography of the heart.
[11794459] Mayo Clin Proc 77(1): 55-71 (2002)
2007  
395
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.
[17296825] N Engl J Med 356(10): 989-97 (2007)
2007  
396
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
[17296824] N Engl J Med 356(10): 998-1008 (2007)
2007  
397
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
[17296823] N Engl J Med 356(10): 1030-9 (2007)
2007  
398
Stent thrombosis in randomized clinical trials of drug-eluting stents.
[17296821] N Engl J Med 356(10): 1020-9 (2007)
2006  
399
Bivalirudin for patients with acute coronary syndromes.
[17124018] N Engl J Med 355(21): 2203-16 (2006)
2005  
400
Early invasive versus selectively invasive management for acute coronary syndromes.
[16162880] N Engl J Med 353(11): 1095-104 (2005)
2001  
401
Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.
[11228280] N Engl J Med 344(9): 645-54 (2001)
1976  
402
Left main stem coronary artery disease. Retrospective review of 26 patients treated surgically or medically.
[1087051] Thorax 31(5): 522-6 (1976)
2001  
403
Coronary artery disease: Part 1. Epidemiology and diagnosis.
[11290684] West J Med 174(4): 257-61 (2001)
1998  
404
Revascularization in coronary artery disease. A review of randomized trial data.
[9584677] West J Med 168(4): 280-5 (1998)
1996  
405
Applying the results of large clinical trials in the management of acute myocardial infarction.
[8775936] West J Med 164(3): 238-48 (1996)
1998  
406
Use of calcium antagonists in post-myocardial infarction patients.
[9426028] J Am Coll Cardiol 31(1): 118-9 (1998)
1998  
407
Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
[9426027] J Am Coll Cardiol 31(1): 111-7 (1998)
1996  
408
Coronary artery stents. American College of Cardiology.
[8772772] J Am Coll Cardiol 28(3): 782-94 (1996)
1995  
409
High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions.
[7642867] J Am Coll Cardiol 26(3): 731-6 (1995)
1995  
410
Percutaneous revascularization of chronic coronary occlusions: an overview.
[7797737] J Am Coll Cardiol 26(1): 1-11 (1995)
1995  
411
Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.
[7775708] J Am Coll Cardiol 25(7 Suppl): 10S-17S (1995)
2002  
412
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
[12356647] Circulation 106(14): 1893-900 (2002)
2001  
413
2001  
414
Current concepts of the pathogenesis of the acute coronary syndromes.
[11457759] Circulation 104(3): 365-72 (2001)
2001  
415
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.
[11413091] Circulation 103(24): 2987-92 (2001)
2001  
416
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
[11401946] Circulation 103(23): 2862-6 (2001)
1998  
417
Landmarks in the development of coronary artery bypass surgery.
[9714098] Circulation 98(5): 466-78 (1998)
1998  
418
Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.
[9631869] Circulation 97(22): 2202-12 (1998)
1998  
419
Thrombolysis for acute myocardial infarction.
[9593569] Circulation 97(16): 1632-46 (1998)
1998  
420
Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction.
[9537346] Circulation 97(12): 1195-206 (1998)
1998  
421
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.
[9521341] Circulation 97(9): 916-31 (1998)
1997  
422
New look to an old symptom: angina pectoris.
[9396481] Circulation 96(10): 3766-73 (1997)
1997  
423
Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.
[9286943] Circulation 96(4): 1152-6 (1997)
1997  
424
Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial.
[9286931] Circulation 96(4): 1074-7 (1997)
1996  
425
Intracoronary stenting. From concept to custom.
[8790021] Circulation 94(5): 882-90 (1996)
1995  
426
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.
[7554219] Circulation 92(8): 2333-42 (1995)
1995  
427
1995  
428
Molecular bases of the acute coronary syndromes.
[7758192] Circulation 91(11): 2844-50 (1995)
2008  
429
A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
[18772058] J Am Coll Cardiol 52(11): 894-904 (2008)
2008  
430
Percutaneous coronary intervention for stable coronary artery disease.
[18772057] J Am Coll Cardiol 52(11): 889-93 (2008)
2008  
431
The effects of medications on myocardial perfusion.
[18672159] J Am Coll Cardiol 52(6): 401-16 (2008)
2008  
432
Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
[18565394] J Am Coll Cardiol 51(25): 2385-95 (2008)
2008  
433
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
[18191746] J Am Coll Cardiol 51(2): 210-47 (2008)
2008  
434
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines.
[18191745] J Am Coll Cardiol 51(2): 172-209 (2008)
2007  
435
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
[18061078] J Am Coll Cardiol 50(23): 2264-74 (2007)
2007  
436
Universal definition of myocardial infarction.
[18036459] J Am Coll Cardiol 50(22): 2173-95 (2007)
2007  
437
The Emperor's new clothes: another cypher versus taxus post-hoc meta-analysis.
[17903639] J Am Coll Cardiol 50(14): 1381-5 (2007)
2007  
438
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
[17903638] J Am Coll Cardiol 50(14): 1373-80 (2007)
2007  
439
ST-segment deviation analysis of the admission 12-lead electrocardiogram as an aid to early diagnosis of acute myocardial infarction with a cardiac magnetic resonance imaging gold standard.
[17825710] J Am Coll Cardiol 50(11): 1021-8 (2007)
2007  
440
Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.
[17765117] J Am Coll Cardiol 50(10): 917-29 (2007)
2007  
441
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
[17692738] J Am Coll Cardiol 50(7): e1-e157 (2007)
2007  
442
Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
[17662400] J Am Coll Cardiol 50(5): 463-70 (2007)
2007  
443
Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.
[17616295] J Am Coll Cardiol 50(2): 119-27 (2007)
2007  
444
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
[17291948] J Am Coll Cardiol 49(6): 734-9 (2007)
2007  
445
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
[17276188] J Am Coll Cardiol 49(5): 616-23 (2007)
2007  
446
Attenuated coronary collateral function after drug-eluting stent implantation: a new downside of drug-eluting stents?
[17207717] J Am Coll Cardiol 49(1): 21-2 (2007)
2006  
447
Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited.
[16697332] J Am Coll Cardiol 47(10): 2112-5 (2006)
2006  
448
Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?
[16386684] J Am Coll Cardiol 47(1): 182-3 (2006)
2006  
449
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.
[16386683] J Am Coll Cardiol 47(1): 175-81 (2006)
2005  
450
Contemporary stent treatment of coronary bifurcations.
[16226167] J Am Coll Cardiol 46(8): 1446-55 (2005)
2004  
451
The quantification of infarct size.
[15489082] J Am Coll Cardiol 44(8): 1533-42 (2004)
2004  
452
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
[15337239] J Am Coll Cardiol 44(5): e213-310 (2004)
2004  
453
Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies.
[15172399] J Am Coll Cardiol 43(11): 1964-72 (2004)
2004  
454
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty.
[15028347] J Am Coll Cardiol 43(6): 936-42 (2004)
2004  
455
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention.
[15013110] J Am Coll Cardiol 43(3): 328-36 (2004)
2003  
456
Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era.
[12932596] J Am Coll Cardiol 42(4): 652-8 (2003)
2003  
457
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes.
[12706924] J Am Coll Cardiol 41(8): 1293-304 (2003)
2003  
458
Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective.
[12644348] J Am Coll Cardiol 41(4 Suppl S): 103S-112S (2003)
2003  
459
"Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: the interventionalist's perspective.
[12644347] J Am Coll Cardiol 41(4 Suppl S): 96S-102S (2003)
2003  
460
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.
[12644346] J Am Coll Cardiol 41(4 Suppl S): 89S-95S (2003)
2003  
461
Myocardial laser revascularization for the treatment of end-stage coronary artery disease.
[12535804] J Am Coll Cardiol 41(2): 173-83 (2003)
2003  
462
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
[12570960] J Am Coll Cardiol 41(1): 159-68 (2003)
2003  
463
Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions.
[12570940] J Am Coll Cardiol 41(1): 26-32 (2003)
2003  
464
Revascularization for acute coronary syndromes in older people.
[12715777] Age Ageing 32(2): 129-35 (2003)
2009  
465
Multiple culprit arteries in patients with ST segment elevation myocardial infarction referred for primary percutaneous coronary intervention.
[19699333] Am J Cardiol 104(5): 619-23 (2009)
2009  
466
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.
[19892045] Am J Cardiol 104(10): 1324-9 (2009)
2010  
467
Contemporary trends in evidence-based treatment for acute myocardial infarction.
[20103026] Am J Med 123(2): 166-72 (2010)
2010  
468
Nutritional treatments for acute myocardial infarction.
[20806996] Altern Med Rev 15(2): 113-23 (2010)
2007  
469
An examination of the evidence supporting the association of dietary cholesterol and saturated fats with serum cholesterol and development of coronary heart disease.
[18072819] Altern Med Rev 12(3): 228-45 (2007)
2007  
470
Should EDTA chelation therapy be used instead of long-term clopidogrel plus aspirin to treat patients at risk from drug-eluting stents?
[17604460] Altern Med Rev 12(2): 152-8 (2007)
2009  
471
The arrythmogenic potential of post-myocardial infarction cytokine treatment.
[19542486] Am J Physiol Heart Circ Physiol 297(2): H508-9 (2009)
2004  
472
Angina pectoris: a review of current and emerging therapies.
[15603242] Am J Manag Care 10(11 Suppl): S332-8 (2004)
2004  
473
A systematic review of the economic burden of chronic angina.
[15603244] Am J Manag Care 10(11 Suppl): S347-57 (2004)
2009  
474
Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.
[19355807] Am J Manag Care 15(2 Suppl): S36-41 (2009)
2009  
475
Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
[19355808] Am J Manag Care 15(2 Suppl): S42-7 (2009)
2009  
476
Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
[19355809] Am J Manag Care 15(2 Suppl): S48-53 (2009)
2002  
477
ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina.
[12458252] BMJ 325(7375): 1287-9 (2002)
2003  
478
Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction.
[12791748] BMJ 326(7401): 1259-61 (2003)
2003  
479
Acute coronary syndrome: ST segment elevation myocardial infarction.
[12816828] BMJ 326(7403): 1379-81 (2003)
2007  
480
Acute coronary syndromes without ST segment elevation.
[17569934] BMJ 334(7606): 1265-9 (2007)
2010  
481
Combined reperfusion strategies in ST-segment elevation MI: Rationale and current role.
[20810873] Cleve Clin J Med 77(9): 629-38 (2010)
2007  
482
New insights into ischemic heart disease in women.
[17708130] Cleve Clin J Med 74(8): 585-94 (2007)
2007  
483
What is the best test for a patient with classic angina?
[17333639] Cleve Clin J Med 74(2): 123-6 (2007)
2009  
484
A new, precise definition of acute myocardial infarction.
[19258462] Cleve Clin J Med 76(3): 159-66 (2009)
2009  
485
The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.
[19332589] Cleve Clin J Med 76 Suppl 1(-): S16-23 (2009)
2009  
486
Importance of platelets and platelet response in acute coronary syndromes.
[19332590] Cleve Clin J Med 76 Suppl 1(-): S2-7 (2009)
2009  
487
Dual antiplatelet therapy in coronary artery disease: a case-based approach.
[19884296] Cleve Clin J Med 76(11): 663-70 (2009)
2009  
488
Chronic coronary artery disease: diagnosis and management.
[19955250] Mayo Clin Proc 84(12): 1130-46 (2009)
2010  
489
Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.
[20118392] Mayo Clin Proc 85(2): 165-71 (2010)
2009  
490
Acute coronary syndromes: Diagnosis and management, part II.
[19880693] Mayo Clin Proc 84(11): 1021-36 (2009)
2009  
491
Acute coronary syndromes: diagnosis and management, part I.
[19797781] Mayo Clin Proc 84(10): 917-38 (2009)
2010  
492
Brain perivascular macrophages and central sympathetic activation after myocardial infarction: heart and brain interaction.
[20142562] Hypertension 55(3): 610-1 (2010)
2007  
493
Avoiding vicious circles: mineralocorticoid receptor antagonism prevents vascular oxidative stress early after myocardial infarction.
[17875816] Hypertension 50(5): 842-3 (2007)
2010  
494
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction.
[20530020] Circulation 121(22): 2437-45 (2010)
2010  
495
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management.
[20516386] Circulation 121(21): 2317-25 (2010)
2002  
496
Mouse model for atherosclerotic plaque rupture.
[11980677] Circulation 105(17): 2010-1 (2002)
2002  
497
Intracoronary brachytherapy: past, present, and future.
[12057979] Circulation 105(23): 2699-700 (2002)
2010  
498
Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
[20956257] Circulation 122(16 Suppl 2): S422-65 (2010)
2010  
499
Bioresorbable stents: the next revolution.
[21098438] Circulation 122(22): 2236-8 (2010)
2010  
500
Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
[20956226] Circulation 122(18 Suppl 3): S787-817 (2010)
2008  
501
Intracoronary administration of abciximab in ST-elevation myocardial infarction.
[18591449] Circulation 118(1): 6-8 (2008)
2004  
502
Microvasculature in acute myocardial ischemia: part I: evolving concepts in pathophysiology, diagnosis, and treatment.
[14734502] Circulation 109(2): 146-9 (2004)
2004  
503
Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment.
[14744956] Circulation 109(3): 310-5 (2004)
2004  
504
Should radial arteries be used routinely for coronary artery bypass grafting?
[15289390] Circulation 110(5): e40-6 (2004)
2004  
505
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
[15466654] Circulation 110(14): e340-437 (2004)
2005  
506
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.
[15687114] Circulation 111(5): 682-96 (2005)
2003  
507
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
[14530185] Circulation 108(14): 1664-72 (2003)
2003  
508
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
[14557340] Circulation 108(15): 1772-8 (2003)
2003  
509
New frontiers in cardiology: drug-eluting stents: Part II.
[12742968] Circulation 107(18): 2383-9 (2003)
2003  
510
Coronary collaterals: an important and underexposed aspect of coronary artery disease.
[12756191] Circulation 107(19): 2507-11 (2003)
2003  
511
New frontiers in cardiology: drug-eluting stents: Part I.
[12732594] Circulation 107(17): 2274-9 (2003)
2010  
512
Treating non-ST-segment elevation acute coronary syndromes: if you aren't sure, at least do no harm.
[20142452] Circulation 121(7): 843-5 (2010)
2007  
513
Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome: a balancing act between plaque stability and rupture.
[17846339] Circulation 116(11): 1214-6 (2007)
2009  
514
Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
[19289638] Circulation 119(12): 1634-42 (2009)
2009  
515
Coronary stents and chronic anticoagulation.
[19332481] Circulation 119(12): 1682-8 (2009)
2009  
516
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.
[19228819] Circulation 119(10): e262-70 (2009)
2009  
517
2009  
518
Early stent thrombosis: past, present, and future.
[19204315] Circulation 119(5): 657-9 (2009)
2009  
519
Coronary artery spasm: a 2009 update.
[19433770] Circulation 119(18): 2531-4 (2009)
2009  
520
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
[19528338] Circulation 119(25): 3198-206 (2009)
2009  
521
Drug-eluting stents in animals and patients: where do we stand today?
[19564555] Circulation 120(2): 101-3 (2009)
2009  
522
Reperfusion therapy for ST-segment elevation myocardial infarction: trials, registries, and guidelines.
[19506103] Circulation 119(24): 3047-9 (2009)
2009  
523
Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.
[19506117] Circulation 119(24): 3101-9 (2009)
2009  
524
Should we manage patients with non-ST segment elevation myocardial infarction with renal failure with an invasive strategy?
[19704091] Circulation 120(10): 828-30 (2009)
2008  
525
"POBA Plus": will the balloon regain its luster?
[18809805] Circulation 118(13): 1309-11 (2008)
2008  
526
Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel.
[18852375] Circulation 118(16): 1607-8 (2008)
2009  
527
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
[19923169] Circulation 120(22): 2271-306 (2009)
2009  
528
The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction.
[19581488] Circulation 120(3): 185-7 (2009)
2009  
529
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
[19131581] Circulation 119(9): 1330-52 (2009)
2009  
530
Endovascular therapy for left main compression syndrome. Case report and literature review.
[19497900] Chest 135(6): 1648-50 (2009)
2008  
531
Coronary stent fracture: detection with 64-section multidetector CT angiography in patients and in vitro.
[19011182] Radiology 249(3): 810-9 (2008)
2008  
532
Functionally relevant coronary artery disease: comparison of 64-section CT angiography with myocardial perfusion SPECT.
[18552310] Radiology 248(2): 414-23 (2008)
2009  
533
CT of coronary artery disease.
[19864526] Radiology 253(2): 317-38 (2009)
2010  
534
Current state of surgical myocardial revascularization.
[20467145] Circ J 74(6): 1031-7 (2010)
2010  
535
Glycoprotein IIb/IIIa inhibitors to facilitate percutaneous intervention in ST-elevation myocardial infarction: the sooner not necessarily the better.
[20647633] Circ J 74(8): 1528-9 (2010)
2011  
536
Physiological assessment of myocardial perfusion using nuclear cardiology would enhance coronary artery disease patient care: which imaging modality is best for evaluation of myocardial ischemia? (SPECT-side).
[21301136] Circ J 75(3): 713-22; discussion 731 (2011)
2011  
537
Paradigm shift from myocardium-derived to plaque-derived biomarkers for very early diagnosis of acute myocardial infarction.
[21532186] Circ J 75(6): 1322-3 (2011)
2011  
538
A Novel Descriptive, Intelligible and Ordered (DINO) classification of coronary bifurcation lesions. Review of current classifications.
[21187658] Circ J 75(2): 299-305 (2011)
2011  
539
A new angle on classifying coronary artery bifurcation stenoses. The DINO system.
[21258163] Circ J 75(2): 263-5 (2011)
2011  
540
Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm.
[21378446] Circ J 75(4): 784-5 (2011)
2011  
541
Physiological and metabolic effects of grafts in coronary artery bypass surgery.
[21415547] Circ J 75(4): 766-72 (2011)
2011  
542
Measurement of procalcitonin in acute coronary syndrome. - Yet another prognostic biomarker?-.
[21467663] Circ J 75(5): 1059-60 (2011)
2011  
543
Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.
[21737949] Circ J 75(8): 1829-30 (2011)
2011  
544
Hyponatremia and arginine vasopressin in early stage of ST-elevation acute myocardial infarction. -Surrogate markers or therapeutic targets?-.
[21737954] Circ J 75(8): 1823-4 (2011)
2010  
545
Off-pump coronary artery bypass vs percutaneous coronary intervention. Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI(PCI-Side).
[21084755] Circ J 74(12): 2750-7 (2010)
2010  
546
Is angioplasty able to become the gold standard of treatment beyond bypass surgery for patients with multivessel coronary artery disease? Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI(PCI-Side).
[21084756] Circ J 74(12): 2744-9 (2010)
2010  
547
The entire coronary arterial system rather than just the culprit lesion should be evaluated in patients with acute coronary syndrome.
[20145340] Circ J 74(3): 430-1 (2010)
2003  
548
Coronary microembolization.
[12655156] Circ J 67(4): 279-86 (2003)
2010  
549
Role of the SDF-1/CXCR4 system in myocardial infarction.
[20118565] Circ J 74(3): 418-23 (2010)
2010  
550
Acute coronary syndrome: insight from angioscopy.
[20118566] Circ J 74(3): 411-7 (2010)
2009  
551
New approaches to the evaluation of coronary endothelial function.
[19246821] Circ J 73(3): 434-5 (2009)
2009  
552
Clinical implications of electrocardiograms for patients with non-ST-segment elevation acute coronary syndromes in the interventional era.
[19346660] Circ J 73(5): 798-805 (2009)
2007  
553
Emerging thrombotic effects of drug eluting stents.
[17229968] Arterioscler Thromb Vasc Biol 27(2): 261-2 (2007)
2002  
554
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.
[11744010] Cardiovasc Res 53(1): 12-30 (2002)
2002  
555
The inflammatory response in myocardial infarction.
[11744011] Cardiovasc Res 53(1): 31-47 (2002)
2006  
556
Aborted myocardial infarction: a new target for reperfusion therapy.
[16543251] Eur Heart J 27(8): 901-4 (2006)
2010  
557
Imaging of coronary atherosclerosis: intravascular ultrasound.
[20823109] Eur Heart J 31(20): 2456-69 (2010)
2010  
558
Guidelines on myocardial revascularization.
[20802248] Eur Heart J 31(20): 2501-55 (2010)
2010  
559
Which antithrombotic to use during PCI?
[20150323] Eur Heart J 31(5): 522-4 (2010)
2010  
560
Mannose-binding lectin: an ancient molecule with new implications in myocardial infarction.
[20233793] Eur Heart J 31(10): 1163-4 (2010)
2010  
561
Is it naive to load only clopidogrel-naive patients prior to PCI?
[20363766] Eur Heart J 31(11): 1298-300 (2010)
2004  
562
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
[15084367] Eur Heart J 25(8): 634-41 (2004)
2004  
563
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes.
[14972418] Eur Heart J 25(3): 190-8 (2004)
2010  
564
Primary angioplasty vs. thrombolysis: the end of the controversy?
[19965864] Eur Heart J 31(6): 634-6 (2010)
2009  
565
Pharmaco-invasive vs. facilitated percutaneous coronary intervention strategies for ST-segment-elevation acute myocardial infarction patients in the new ESC Guidelines.
[19952008] Eur Heart J 30(23): 2817 (2009)
2010  
566
Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
[20064819] Eur Heart J 31(9): 1032-5 (2010)
2007  
567
Clinical course of isolated stable angina due to coronary heart disease.
[17562665] Eur Heart J 28(16): 1928-35 (2007)
2007  
568
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.
[17289741] Eur Heart J 28(13): 1583-91 (2007)
2007  
569
Drug-eluting stents: effective and safe for every patient and every lesion?
[17938127] Eur Heart J 28(21): 2559-60 (2007)
2009  
570
Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC).
[19001473] Eur Heart J 30(3): 278-89 (2009)
2007  
571
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
[17456480] Eur Heart J 28(10): 1193-204 (2007)
2009  
572
Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.
[19357105] Eur Heart J 30(11): 1322-30 (2009)
2009  
573
Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented?
[19359325] Eur Heart J 30(9): 1035-7 (2009)
2009  
574
Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling?
[19460842] Eur Heart J 30(12): 1431-3 (2009)
2009  
575
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.
[19109347] Eur Heart J 30(9): 1038-45 (2009)
2008  
576
Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries?
[18230806] Eur Heart J 29(6): 695-7 (2008)
2008  
577
Acute reperfusion strategies for ST-segment elevation myocardial infarction.
[18310670] Eur Heart J 29(5): 571-2 (2008)
2010  
578
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
[19755402] Eur Heart J 31(1): 35-49 (2010)
2009  
579
Thrombectomy in acute ST-elevation myocardial infarction: keep it simple.
[19726438] Eur Heart J 30(18): 2180-1 (2009)
2009  
580
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.
[19726437] Eur Heart J 30(18): 2193-203 (2009)
2009  
581
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
[19168529] Eur Heart J 30(4): 459-68 (2009)
2010  
582
Prevalence of embolic signals in acute coronary syndromes.
[20044527] Stroke 41(2): 261-6 (2010)
2009  
583
Optimizing screening and management of asymptomatic coronary artery disease in patients with stroke and patients with transient ischemic attack.
[19679844] Stroke 40(10): 3407-9 (2009)
2011  
584
Stent fracture: case report and literature review.
[21553613] Rev Port Cardiol 30(2): 213-21 (2011)
2004  
585
2004  
586
Coronary heart disease in diabetes mellitus: risk factors and epidemiology.
[15641298] Rev Port Cardiol 23(10): 1359-66 (2004)
2003  
587
Pathophysiology of unstable angina: implications for secondary prevention.
[12940185] Rev Port Cardiol 22(5): 727-33 (2003)
2007  
588
Innovation, evidence and the real world. A surgeon's perspective on the treatment of three-vessel or left main coronary artery disease with drug-eluting stents.
[18297841] Rev Port Cardiol 26(11): 1199-211 (2007)
2009  
589
Invasive strategy for non-ST elevation acute coronary syndromes revisited.
[19634495] Rev Port Cardiol 28(4): 375-81 (2009)
2009  
590
Spontaneous coronary artery dissection: a diagnosis to consider in acute coronary syndromes.
[19697798] Rev Port Cardiol 28(6): 707-13 (2009)
2009  
591
When will we see evaluation of coronary function as a whole and not merely angiographic assessment of coronary morphology?
[19894658] Rev Port Cardiol 28(7-8): 793-7 (2009)
2002  
592
2009  
593
Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
[19279027] Europace 11(4): 407-8 (2009)
2009  
594
The ECG in localizing the culprit lesion in acute inferior myocardial infarction: a plea for lead V4R?
[19880408] Europace 11(11): 1421-2 (2009)
2008  
595
Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium.
[18071302] Br J Pharmacol 153(6): 1128-32 (2008)
2008  
596
Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion.
[18253087] Autophagy 4(4): 416-21 (2008)
2002  
597
Acute myocardial infarction in young adults: causes and management.
[11796868] Postgrad Med J 78(915): 27-30 (2002)
2004  
598
Drug-eluting stents: new era and new concerns.
[14760171] Postgrad Med J 80(939): 13-8 (2004)
2003  
599
2007  
600
Non-invasive treatment of ST elevation myocardial infarction.
[18057168] Postgrad Med J 83(986): 725-30 (2007)
2007  
601
Primary PCI for myocardial infarction with ST-segment elevation.
[17202455] N Engl J Med 356(1): 47-54 (2007)
2009  
602
Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?
[19547626] Dtsch Arztebl Int 106(15): 253-61 (2009)
2004  
603
Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction.
[15505262] CMAJ 171(9): 1039-41 (2004)
2004  
604
Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction.
[15505263] CMAJ 171(9): 1042-4 (2004)
2011  
605
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
[21888837] Health Technol Assess 15(31): 1-178 (2011)
2010  
606
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention.
[20507801] Health Technol Assess 14 Suppl 1(-): 31-8 (2010)
2004  
607
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
[15461876] Health Technol Assess 8(38): iii-iv, 1-196 (2004)
2009  
608
The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.
[19573471] Health Technol Assess 13(31): iii-iv, ix-xi, 1-77 (2009)
2005  
609
Large and micro coronary vascular involvement in diabetes.
[16415482] Pharmacol Rep 57 Suppl(-): 3-9 (2005)
2005  
610
Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy.
[16415496] Pharmacol Rep 57 Suppl(-): 151-5 (2005)
2009  
611
The past, the present and the future of experimental research on myocardial ischemia and protection.
[19307688] Pharmacol Rep 61(1): 3-12 (2009)
2011  
612
Variant angina associated with coronary artery endothelial dysfunction and myocardial bridge: a case report and review of the literature.
[22041365] Intern Med 50(21): 2601-6 (2011)
2005  
613
Endothelial function and coronary spastic angina.
[15750267] Intern Med 44(2): 91-9 (2005)
2009  
614
123I-BMIPP fatty acid analogue imaging is a novel diagnostic and prognostic approach following acute myocardial infarction.
[19907882] Singapore Med J 50(10): 943-8 (2009)
2005  
615
Evidence-based management of acute myocardial infarction in the elderly--current perspectives.
[16369378] MedGenMed 7(1): 73 (2005)
2008  
616
2009  
617
Myocardial infarction (ST-elevation).
[19445779] Clin Evid (Online) 2009(-): - (2009)
2009  
618
Acute coronary syndrome (unstable angina and non-ST elevation MI).
[19445778] Clin Evid (Online) 2009(-): - (2009)
2008  
619
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
[18594042] JAMA 300(1): 71-80 (2008)
2005  
620
A simplified approach to the management of non-ST-segment elevation acute coronary syndromes.
[15657328] JAMA 293(3): 349-57 (2005)
2010  
621
A 43-year-old man with angina, elevated troponin, and lateral ST depression: management of acute coronary syndromes.
[19952308] JAMA 303(1): 54-63 (2010)
2009  
622
Persistent chest pain and no obstructive coronary artery disease.
[19351944] JAMA 301(14): 1468-74 (2009)
2009  
623
Sex differences in mortality following acute coronary syndromes.
[19706861] JAMA 302(8): 874-82 (2009)
2010  
624
Electrocardiographic identification of the culprit coronary artery in inferior wall ST elevation myocardial infarction.
[20548974] Can J Cardiol 26(6): 293-6 (2010)
2004  
625
Congenital anomalies of the coronary circulation.
[15054517] Can J Cardiol 20(3): 353-6 (2004)
2004  
626
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
[15332148] Can J Cardiol 20(10): 977-1025 (2004)
2003  
627
Prognostic significance of ventricular arrhythmias post-myocardial infarction.
[14631474] Can J Cardiol 19(12): 1393-404 (2003)
2003  
628
Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspective.
[12915930] Can J Cardiol 19(9): 1033-9 (2003)
2003  
629
Statin therapy and the management of acute coronary syndromes.
[12876613] Can J Cardiol 19(8): 921-7 (2003)
2005  
630
The efficacy of sirolimus- and paclitaxel-eluting stents: a meta-analysis of randomized controlled trials.
[15940356] Can J Cardiol 21(7): 581-7 (2005)
2005  
631
Kawasaki disease, myocardial infarction and coronary artery revascularization.
[15940359] Can J Cardiol 21(7): 601-4 (2005)
2009  
632
Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials.
[19521570] Can J Cardiol 25 Suppl A(-): 21A-27A (2009)
2006  
633
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.
[16801997] Can J Cardiol 22(8): 663-77 (2006)
2011  
634
Chronic stable angina: percutaneous coronary intervention or medication?
[21642073] Hellenic J Cardiol 52(3): 246-52 (2011)
2010  
635
Clopidogrel and cardiovascular diseases: recommendations for its correct use.
[20118052] Hellenic J Cardiol 51(1): 83-6 (2010)
2007  
636
Coronary revascularisation in patients with chronic renal disease.
[17715613] Hellenic J Cardiol 48(4): 218-27 (2007)
2005  
637
Current trends in surgical reperfusion of the myocardium.
[15981552] Hellenic J Cardiol 46(3): 174-82 (2005)
2009  
638
Conduction disturbances in acute myocardial infarction: a clinical study and brief review of the literature.
[19465358] Hellenic J Cardiol 50(3): 179-84 (2009)
2008  
639
Erectile dysfunction and coronary artery disease: a relationship for disclosure.
[18350775] Hellenic J Cardiol 49(1): 1-6 (2008)
2011  
640
Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET). A review of the BASKET trials.
[21882123] Swiss Med Wkly 141(-): w13263 (2011)
2005  
641
Coronary stent infection: a rare but severe complication of percutaneous coronary intervention.
[16208586] Swiss Med Wkly 135(33-34): 483-7 (2005)
2009  
642
Detection of vulnerable plaques rather than the culprit lesions in patients with acute coronary syndrome using virtual histology intravascular ultrasound imaging.
[19323920] Chin Med J (Engl) 122(6): 610-1 (2009)
2007  
643
Late stent thrombosis: a not negligible issue after drug-eluting stent implantation.
[17442197] Chin Med J (Engl) 120(7): 531-2 (2007)
2009  
644
Clinical outcomes of serolimus-eluting stents versus bare metal stents in ST-segment elevation myocardial infarction patients: a meta-analysis.
[19187623] Chin Med J (Engl) 122(1): 88-92 (2009)
2007  
645
2007  
646
What is the patency of the gastroepiploic artery when used for coronary artery bypass grafting?
[17669877] Interact Cardiovasc Thorac Surg 6(3): 397-402 (2007)
2010  
647
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
[20859545] Vasc Health Risk Manag 6(-): 749-74 (2010)
2010  
648
The utility of troponin measurement to detect myocardial infarction: review of the current findings.
[20859540] Vasc Health Risk Manag 6(-): 691-9 (2010)
2010  
649
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.
[20730020] Vasc Health Risk Manag 6(-): 635-56 (2010)
2011  
650
Extended-release ranolazine: critical evaluation of its use in stable angina.
[21915171] Vasc Health Risk Manag 7(-): 535-9 (2011)
2011  
651
Novel drug-eluting stents in the treatment of de novo coronary lesions.
[21415924] Vasc Health Risk Manag 7(-): 103-18 (2011)
2011  
652
Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification.
[21490939] Vasc Health Risk Manag 7(-): 143-51 (2011)
2010  
653
Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
[21057581] Vasc Health Risk Manag 6(-): 963-77 (2010)
2010  
654
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.
[20957131] Vasc Health Risk Manag 6(-): 855-67 (2010)
2010  
655
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention.
[20234778] Vasc Health Risk Manag 6(-): 39-45 (2010)
2009  
656
Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction.
[19436656] Vasc Health Risk Manag 5(1): 249-56 (2009)
2007  
657
Update on stents: recent studies on the TAXUS stent system in small vessels.
[17969378] Vasc Health Risk Manag 3(4): 481-90 (2007)
2007  
658
Utilizing enoxaparin in the management of STEMI.
[18078020] Vasc Health Risk Manag 3(5): 691-700 (2007)
2007  
659
Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome.
[17580732] Vasc Health Risk Manag 3(2): 221-8 (2007)
2007  
660
Coronary artery bypass grafting versus percutaneous intervention in heart failure.
[17679351] Scand J Surg 96(2): 107-10 (2007)
2010  
661
Therapeutic goals in patients with refractory chronic angina.
[20450851] Rev Esp Cardiol 63(5): 571-82 (2010)
2010  
662
Opportunities to improve care for patients with ST-segment elevation myocardial infarction: Focusing on how to deliver the care.
[20450842] Rev Esp Cardiol 63(5): 509-12 (2010)
2010  
663
Acute coronary syndrome in patients with a coronary artery bypass graft.
[20450844] Rev Esp Cardiol 63(5): 516-7 (2010)
2009  
664
ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation.
[19268074] Rev Esp Cardiol 62(3): 293, e1-47 (2009)
2009  
665
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
[19401120] Rev Esp Cardiol 62(4): 354-64 (2009)
2009  
666
Towards the complete characterization of myocardial infarcts by magnetic resonance imaging.
[19706239] Rev Esp Cardiol 62(8): 847-50 (2009)
2009  
667
Ischemic cardiomyopathy: a clinical nuclear cardiology perspective.
[19706246] Rev Esp Cardiol 62(8): 903-17 (2009)
2008  
668
Coronary atherothrombotic disease: progress in antiplatelet therapy.
[18462654] Rev Esp Cardiol 61(5): 501-13 (2008)
2010  
669
Update on clinical imaging of coronary plaque in acute coronary syndrome.
[20372756] Ann Acad Med Singapore 39(3): 203-9 (2010)
2010  
670
Current trends in diagnostic biomarkers of acute coronary syndrome.
[20372757] Ann Acad Med Singapore 39(3): 210-5 (2010)
2010  
671
Risk stratification for sudden cardiac death after acute myocardial infarction.
[20372761] Ann Acad Med Singapore 39(3): 237-46 (2010)
2005  
672
Nuclear cardiology in acute coronary syndromes.
[15724136] Q J Nucl Med Mol Imaging 49(1): 59-71 (2005)
2005  
673
Assessment of myocardial viability in chronic ischemic heart disease: current status.
[15724138] Q J Nucl Med Mol Imaging 49(1): 81-96 (2005)
2004  
674
Biochemical markers of myocardial injury.
[15096441] Br J Anaesth 93(1): 63-73 (2004)
2005  
675
Coronary artery stents: identification and evaluation.
[16049279] J Clin Pathol 58(8): 795-804 (2005)
2009  
676
Review of the treatment of acute coronary syndrome in elderly patients.
[19966912] Clin Interv Aging 4(-): 435-44 (2009)
2010  
677
Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability.
[20214535] Expert Rev Mol Diagn 10(2): 159-71 (2010)
2007  
678
Cardiac biomarkers: myths, facts and future horizons.
[18020898] Expert Rev Mol Diagn 7(6): 693-7 (2007)
2005  
679
Will drug-eluting stents replace coronary artery bypass surgery?
[16392212] Tex Heart Inst J 32(3): 323-30 (2005)
2005  
680
Stents or surgery: the case for stents.
[16392213] Tex Heart Inst J 32(3): 331-8 (2005)
2005  
681
Drug-eluting stents: current issues.
[16392222] Tex Heart Inst J 32(3): 372-7 (2005)
2010  
682
Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.
[20548817] Tex Heart Inst J 37(3): 336-40 (2010)
2010  
683
Unintended consequences: avoiding restenosis and stent thrombosis.
[20548818] Tex Heart Inst J 37(3): 341-2 (2010)
2010  
684
Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review.
[20844620] Tex Heart Inst J 37(4): 449-54 (2010)
2010  
685
Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials.
[20978561] Tex Heart Inst J 37(5): 516-24 (2010)
2010  
686
Ranolazine: a new approach to treating an old problem.
[21224931] Tex Heart Inst J 37(6): 641-7 (2010)
2010  
687
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).
[20401284] Tex Heart Inst J 37(2): 141-8 (2010)
2010  
688
Acute myocardial infarction associated with nonbacterial thrombotic endocarditis.
[20401296] Tex Heart Inst J 37(2): 208-12 (2010)
2010  
689
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).
[20548800] Tex Heart Inst J 37(3): 262-75 (2010)
2010  
690
Advances in surgical treatment of acute and chronic coronary artery disease.
[20548814] Tex Heart Inst J 37(3): 328-30 (2010)
2010  
691
Revascularization options in patients with chronic kidney disease.
[20200622] Tex Heart Inst J 37(1): 9-18 (2010)
2009  
692
Contemporary therapy of acute ST-elevation myocardial infarction.
[19693298] Tex Heart Inst J 36(4): 273-81 (2009)
2007  
693
New European guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction--what are the new and key messages.
[18062559] Pol Arch Med Wewn 117(9): 391-3 (2007)
2010  
694
Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.
[20395340] J Nucl Med 51 Suppl 1(-): 102S-106S (2010)
2010  
695
Imaging atherosclerosis and vulnerable plaque.
[20395341] J Nucl Med 51 Suppl 1(-): 51S-65S (2010)
2010  
696
Imaging myocardial metabolic remodeling.
[20457796] J Nucl Med 51 Suppl 1(-): 88S-101S (2010)
2009  
697
The clinical value of myocardial blood flow measurement.
[19525470] J Nucl Med 50(7): 1076-87 (2009)
2009  
698
Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy.
[19631912] Heart Rhythm 6(8 Suppl): S91-7 (2009)
2008  
699
Surgery for the failing heart after myocardial infarction.
[19028641] Anadolu Kardiyol Derg 8 Suppl 2(-): 93-100 (2008)
2008  
700
Surgery as early revascularization after acute myocardial infarction.
[19028640] Anadolu Kardiyol Derg 8 Suppl 2(-): 84-92 (2008)
2008  
701
Angioplasty as early revascularization in acute myocardial infarction.
[19028639] Anadolu Kardiyol Derg 8 Suppl 2(-): 77-83 (2008)
2007  
702
Update on ACC/ESC criteria for acute ST-elevation myocardial infarction.
[17584670] Anadolu Kardiyol Derg 7 Suppl 1(-): 14-5 (2007)
2006  
703
The radial artery as a conduit for coronary artery bypass grafting: review of current knowledge.
[16766281] Anadolu Kardiyol Derg 6(2): 153-62 (2006)
2010  
704
Everolimus-eluting stents: insights from the SPIRIT IV and COMPARE trials.
[20828341] Expert Rev Cardiovasc Ther 8(9): 1207-10 (2010)
2010  
705
2009  
706
Evolution of stents: past, present and future.
[19419249] Expert Rev Cardiovasc Ther 7(5): 443-6 (2009)
2005  
707
Evolving role of clopidogrel in acute coronary syndromes.
[16292986] Expert Rev Cardiovasc Ther 3(6): 977-80 (2005)
2008  
708
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management.
[18402533] Expert Rev Cardiovasc Ther 6(4): 435-7 (2008)
2004  
709
Collateralization and the response to obstruction of epicardial coronary arteries.
[15100419] QJM 97(5): 259-72 (2004)
2010  
710
Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences.
[19559709] J Mol Cell Cardiol 48(3): 558-63 (2010)
2010  
711
Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction.
[19682461] J Mol Cell Cardiol 48(3): 483-9 (2010)
2007  
712
Oxygen-regulated protein 150 and prognosis following myocardial infarction.
[17176249] Clin Sci (Lond) 112(9): 477-84 (2007)
2007  
713
Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysis.
[18036252] BMC Med 5(-): 35 (2007)
2011  
714
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
[21792295] Drug Des Devel Ther 5(-): 325-80 (2011)
2007  
715
Management strategies for ST-elevation myocardial infarction in the emergency department.
[17844713] WMJ 106(4): 219-24 (2007)
2007  
716
Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.
[17646609] Arch Intern Med 167(14): 1539-44 (2007)
2005  
717
Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes.
[16157831] Arch Intern Med 165(16): 1870-6 (2005)
2004  
718
Management of acute coronary syndromes: an update.
[15145891] Heart 90(6): 698-706 (2004)
2004  
719
Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction.
[15201236] Heart 90(7): 729-31 (2004)
2008  
720
Comorbid conditions and outcomes after percutaneous coronary intervention.
[17923464] Heart 94(11): 1424-8 (2008)
2007  
721
Coronary stenting: why size matters.
[18003677] Heart 93(12): 1500-1 (2007)
2007  
722
Non-invasive screening for coronary artery disease: calcium scoring.
[18003695] Heart 93(12): 1620-9 (2007)
2007  
723
Antiplatelet treatment for coronary heart disease.
[17228079] Heart 93(2): 258-65 (2007)
2010  
724
Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting.
[20603504] J Invasive Cardiol 22(7): 322-6 (2010)
2010  
725
Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
[20603502] J Invasive Cardiol 22(7): 312-6 (2010)
2011  
726
Use of low-molecular-weight heparins during percutaneous coronary intervention.
[21183762] J Invasive Cardiol 23(1): 1-8 (2011)
2011  
727
Thrombotic occlusion of a large septal perforator presenting as ST-segment elevation in V1-V2 and treated with aspiration thrombectomy: a brief review of the literature.
[21183777] J Invasive Cardiol 23(1): E255-9 (2011)
2011  
728
High incidence of inaccurate stent placement in the treatment of coronary aorto-ostial disease.
[21828393] J Invasive Cardiol 23(8): 322-6 (2011)
2011  
729
Potential contribution of open-cell stent design to balloon entrapment and review of techniques to recover.
[21828403] J Invasive Cardiol 23(8): E183-7 (2011)
2010  
730
Management of spontaneous coronary artery dissection in the primary percutaneous coronary intervention era.
[21041853] J Invasive Cardiol 22(11): 549-53 (2010)
2010  
731
Drug-eluting stent versus bare-metal stent in acute ST-segment elevation myocardial infarction: a word of caution.
[20351385] J Invasive Cardiol 22(4): 159-60 (2010)
2010  
732
Spontaneous coronary artery dissection: aggressive vs. conservative therapy.
[20440039] J Invasive Cardiol 22(5): 222-8 (2010)
2010  
733
Unresolved issues associated with early initiation of antiplatelet therapy in acute coronary syndromes.
[20048399] J Invasive Cardiol 22(1): 40-4 (2010)
2007  
734
Towards an understanding of the role of rescue angioplasty for failed fibrinolysis: comparison of the MERLIN, RESCUE and REACT trials.
[17827503] J Invasive Cardiol 19(9): 359-68 (2007)
2007  
735
Percutaneous coronary intervention for persistent complete heart block complicating inferior myocardial infarction.
[18180531] J Invasive Cardiol 19(12): E372-4 (2007)
2007  
736
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
[18180524] J Invasive Cardiol 19(12): 525-38; quiz 539-40 (2007)
2009  
737
Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention.
[19258641] J Invasive Cardiol 21(3): 110-3 (2009)
2008  
738
Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity.
[18830004] J Invasive Cardiol 20(10): 560-2 (2008)
2008  
739
Mechanisms of atherothrombosis in chronic obstructive pulmonary disease.
[18488431] Int J Chron Obstruct Pulmon Dis 3(1): 89-96 (2008)
2004  
740
The role of myeloperoxidase in the pathogenesis of coronary artery disease.
[15507760] Jpn J Infect Dis 57(5): S21-2 (2004)
2010  
741
Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design.
[20074348] Trials 11(-): 5 (2010)
2011  
742
Which is the best technique for CABG; OPCAB, on-pump arrest CABG or on-pump beating CABG?
[21697780] Ann Thorac Cardiovasc Surg 17(3): 218-20 (2011)
2009  
743
Left ventricular reconstruction with or without mitral annuloplasty.
[19597391] Ann Thorac Cardiovasc Surg 15(3): 165-70 (2009)
2011  
744
Increased heart rate and atherosclerosis: potential implications of ivabradine therapy.
[21526046] World J Cardiol 3(4): 101-4 (2011)
2011  
745
Advantages and disadvantages of biodegradable platforms in drug eluting stents.
[21499496] World J Cardiol 3(3): 84-92 (2011)
2011  
746
Percutaneous treatment in acute coronary syndromes.
[22053219] World J Cardiol 3(10): 315-21 (2011)
2011  
747
Coronary computed tomography angiography in coronary artery disease.
[21949572] World J Cardiol 3(9): 303-10 (2011)
2010  
748
Multislice CT angiography in coronary artery disease: Technical developments, radiation dose and diagnostic value.
[21160611] World J Cardiol 2(10): 333-43 (2010)
2003  
749
Management of patients undergoing percutaneous coronary revascularization.
[12859162] Ann Intern Med 139(2): 123-36 (2003)
2003  
750
Evidence for use of coronary stents. A hierarchical bayesian meta-analysis.
[12755549] Ann Intern Med 138(10): 777-86 (2003)
2003  
751
Why have stents replaced balloons? Underwhelming evidence.
[12755557] Ann Intern Med 138(10): 842-3 (2003)
2005  
752
Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start?
[16555620] Trans Am Clin Climatol Assoc 116(-): 273-80; discussion 281 (2005)
2007  
753
Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization.
[17418368] Trends Cardiovasc Med 17(3): 77-83 (2007)
2010  
754
New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems.
[20716758] Circ Cardiovasc Interv 3(4): 384-93 (2010)
2010  
755
Pharmacoinvasive strategy for ST-segment elevation myocardial infarction: wading through the treatment options.
[20716756] Circ Cardiovasc Interv 3(4): 294-6 (2010)
2008  
756
Catheter-based treatment of coronary artery disease: past, present, and future.
[20031656] Circ Cardiovasc Interv 1(1): 60-73 (2008)
2009  
757
2009  
758
Off-label use and the spectre of drug-eluting stent thrombosis.
[20031728] Circ Cardiovasc Interv 2(4): 273-6 (2009)
2009  
759
Drug-eluting balloon: the comeback kid?
[20031739] Circ Cardiovasc Interv 2(4): 352-8 (2009)
2009  
760
Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
[20031735] Circ Cardiovasc Interv 2(4): 323-9 (2009)
2004  
761
Doppler echocardiographic assessment of coronary artery disease: a challenge becomes reality.
[15113005] Eur J Echocardiogr 5(1): 5-7 (2004)
2004  
762
Role of echocardiography in acute coronary syndromes.
[15036017] Eur J Echocardiogr 5(2): 97-8 (2004)
2006  
763
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
[16451297] Int J Clin Pract 60(2): 222-8 (2006)
2008  
764
Signs and symptoms in diagnosing acute myocardial infarction and acute coronary syndrome: a diagnostic meta-analysis.
[18307844] Br J Gen Pract 58(547): 105-11 (2008)
2011  
765
Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.
[21468241] Core Evid 6(-): 31-42 (2011)
2009  
766
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.
[19286090] Lancet 373(9667): 911-8 (2009)
2010  
767
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
[20221852] Rev Endocr Metab Disord 11(1): 75-86 (2010)
2010  
768
Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease.
[20200615] Neth Heart J 18(2): 90-8 (2010)
2007  
769
Hybrid approach for complex coronary artery and valve disease: a clinical follow-up study.
[18167565] Neth Heart J 15(10): 327-8 (2007)
2009  
770
Late stent thrombosis, endothelialisation and drug-eluting stents.
[19421365] Neth Heart J 17(4): 177-80 (2009)
2007  
771
Multivessel coronary artery disease: how do we treat it?
[18297143] Timely Top Med Cardiovasc Dis 11(-): E15 (2007)
2007  
772
2007  
773
Erythropoietin treatment for ischemic cardiomyopathy: anemia correction and myocardial protection.
[18301786] Timely Top Med Cardiovasc Dis 11(-): E33 (2007)
2011  
774
Management of refractory angina pectoris.
[21769814] Cardiol J 18(4): 343-51 (2011)
2009  
775
Myocardial infarction in young people.
[19653171] Cardiol J 16(4): 307-11 (2009)
2011  
776
Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology.
[20972835] Int J Cardiovasc Imaging 27(1): 7-24 (2011)
2011  
777
Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual?
[20454931] Int J Cardiovasc Imaging 27(7): 965-8 (2011)
2008  
778
Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography.
[18373211] Int J Cardiovasc Imaging 24(7): 751-9 (2008)
2011  
779
Emerging therapies for acute coronary syndromes.
[22028691] Front Pharmacol 2(-): 61 (2011)
2011  
780
Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.
[21780334] J Manag Care Pharm 17(5 Suppl): S1-15 (2011)
2010  
781
Pharmacotherapy for end-stage coronary artery disease.
[20088742] Expert Opin Pharmacother 11(2): 207-13 (2010)
2009  
782
Coronary microvascular resistance: methods for its quantification in humans.
[19468781] Basic Res Cardiol 104(5): 485-98 (2009)
2011  
783
The anti-ischemic and anti-anginal properties of statins.
[21107759] Curr Atheroscler Rep 13(1): 43-50 (2011)
2004  
784
Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary atherosclerotic plaque.
[15598352] Cardiovasc Ultrasound 2(-): 29 (2004)
2008  
785
Transthoracic echocardiographic imaging of coronary arteries: tips, traps, and pitfalls.
[18241346] Cardiovasc Ultrasound 6(-): 7 (2008)
2011  
786
Circulating very small embryonic-like stem cells in cardiovascular disease.
[21165781] J Cardiovasc Transl Res 4(2): 138-44 (2011)
2010  
787
Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.
[20632221] J Cardiovasc Transl Res 3(5): 478-86 (2010)
2009  
788
2010  
789
Electrocardiologic and related methods of non-invasive detection and risk stratification in myocardial ischemia: state of the art and perspectives.
[21063467] Ger Med Sci 8(-): Doc27 (2010)
2011  
790
Reduction of myocardial infarct size by dronedarone in pigs--a pleiotropic action?
[21544523] Cardiovasc Drugs Ther 25(3): 197-201 (2011)
2008  
791
Glucose-insulin therapy, plasma substrate levels and cardiac recovery after cardiac ischemic events.
[18266096] Cardiovasc Drugs Ther 22(2): 125-31 (2008)
2010  
792
A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.
[20631859] Exp Clin Cardiol 15(2): e20-4 (2010)
2009  
793
The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients.
[19675816] Exp Clin Cardiol 14(2): e25-30 (2009)
2010  
794
Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: a meta-analysis.
[20379863] J Nucl Cardiol 17(3): 470-8 (2010)
2009  
795
The value of multi-slice-computed tomography coronary angiography for risk stratification.
[19763728] J Nucl Cardiol 16(6): 970-80 (2009)
2010  
796
The potential protective effects of taurine on coronary heart disease.
[19592001] Atherosclerosis 208(1): 19-25 (2010)
2010  
797
2007  
798
Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndrome.
[18160760] Int Heart J 48(6): 677-88 (2007)
2009  
799
The inflammatory response and cardiac repair after myocardial infarction.
[19949583] Korean Circ J 39(10): 393-8 (2009)
2010  
800
Nonacute coronary syndrome anginal chest pain.
[20380951] Med Clin North Am 94(2): 201-16 (2010)
2009  
801
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.
[20031871] Circ Cardiovasc Qual Outcomes 2(5): 414-20 (2009)
2010  
802
Nitrates and nitrites in the treatment of ischemic cardiac disease.
[20539102] Cardiol Rev 18(4): 190-7 (2010)
2011  
803
Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.
[21461336] Int J Hypertens 2011(-): 904742 (2011)
2007  
804
Delivery of large biopharmaceuticals from cardiovascular stents: a review.
[17929968] Biomacromolecules 8(11): 3281-93 (2007)
2007  
805
Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi-detector computed tomographic angiography.
[18093295] BMC Cardiovasc Disord 7(-): 39 (2007)
2010  
806
The underutilization of adjunctive pharmacotherapy in treating acute coronary syndrome patients admitted to a tertiary care hospital in southwest region, saudi arabia.
[21577376] Heart Views 11(3): 99-102 (2010)
2007  
807
Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder?
[17704043] Hormones (Athens) 6(2): 120-31 (2007)
2011  
808
Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target.
[21605013] Clin Chem Lab Med 49(9): 1397-404 (2011)
2010  
809
A meta-analysis of randomized trials on clinical outcomes of paclitaxel-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction patients.
[20872982] J Zhejiang Univ Sci B 11(10): 754-61 (2010)
2008  
810
Molecular genetics of myocardial infarction.
[18704761] Genomic Med 2(1-2): 7-22 (2008)
2011  
811
Genetic variants in the KIF6 region and coronary event reduction from statin therapy.
[20886236] Hum Genet 129(1): 17-23 (2011)
2011  
812
Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.
[21389642] J Nihon Med Sch 78(1): 4-12 (2011)
2011  
813
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.
[21915365] Int J Mol Epidemiol Genet 2(3): 261-85 (2011)
2011  
814
Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective.
[21501474] Vasc Cell 3(1): 8 (2011)
2008  
815
Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.
[19019272] CJEM 10(3): 215-23 (2008)
2010  
816
Periprocedural myocardial infarction: prevalence, prognosis, and prevention.
[21156928] Circ Cardiovasc Interv 3(6): 602-10 (2010)
2010  
817
Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?
[21156927] Circ Cardiovasc Interv 3(6): 528-30 (2010)
2011  
818
Cardiac imaging after myocardial infarction.
[21163851] Eur Heart J 32(3): 272-83 (2011)
2011  
819
Routine early coronary angioplasty after thrombolysis in acute ST-elevation myocardial infarction: lysis is not the final step.
[21183499] Eur Heart J 32(8): 927-30 (2011)
2010  
820
Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature.
[20506492] Catheter Cardiovasc Interv 76(7): 942-8 (2010)
2010  
821
Practical tips and tricks for the measurement of fractional flow reserve.
[20506385] Catheter Cardiovasc Interv 76(7): 978-85 (2010)
2010  
822
Clinical value of diagnostic instruments for ruling out acute coronary syndrome in patients with chest pain: a systematic review.
[20682952] Emerg Med J 27(12): 896-902 (2010)
2011  
823
Persistent sensitivity disorders at the radial artery and saphenous vein graft harvest sites: a neglected side effect of coronary artery bypass grafting procedures.
[21177115] Eur J Cardiothorac Surg 40(1): 221-6 (2011)
2011  
824
Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition--which conduit offers better patency? A systematic review and meta-analysis.
[21167726] Eur J Cardiothorac Surg 40(1): 208-20 (2011)
2010  
825
Corruption of coronary collateral growth in metabolic syndrome: Role of oxidative stress.
[21191543] World J Cardiol 2(12): 421-7 (2010)
2010  
826
How to solve difficult side branch access?
[21930495] EuroIntervention 6 Suppl J(): J72-80 (2010)
PMC   
827
Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality.
[22686200] Clin Transl Sci 5(3):235-42 (2012)
PMC   
828
Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction.
[24432306] Fam Med Med Sci Res 2(2):108 (2013)
PMC   
829
One-year clinical outcomes of BioMatrix-Biolimus A9 eluting stent: the e-BioMatrix multicenter post marketing surveillance registry in India.
[24206883] Indian Heart J 65(5):593-9 (2013)
PMC   
830
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.
[23993004] Indian Heart J 65(4):436-41 (2013)
PMC   
831
ST segment elevations: always a marker of acute myocardial infarction?
[23993002] Indian Heart J 65(4):412-23 (2013)
PMC   
832
Erosion/malapposition of a sirolimus eluting stent - optical coherence tomography image - a case report.
[23253419] Indian Heart J 64(6):610-3 (2012)
PMC   
833
Accuracy of two-dimensional speckle tracking echocardiography for the detection of significant coronary stenosis.
[24459565] J Cardiovasc Ultrasound 21(4):177-82 (2013)
PMC   
834
Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia.
[23172397] J Vasc Res 50(2):100-8 (2013)
PMC   
835
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
[22814783] JACC Cardiovasc Interv 5(7):769-76 (2012)
PMC   
836
Circulating Th22 and Th9 levels in patients with acute coronary syndrome.
[24453425] Mediators Inflamm 2013():635672 (2013)
PMC   
837
Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes.
[24385687] Mediators Inflamm 2013():764082 (2013)
PMC   
838
Ambient fine particulate air pollution triggers ST-elevation myocardial infarction, but not non-ST elevation myocardial infarction: a case-crossover study.
[24382024] Part Fibre Toxicol 11():1 (2014)
PMC   
839
Functional analysis LRP6 novel mutations in patients with coronary artery disease.
[24427284] PLoS One 9(1):e84345 (2014)
PMC   
840
Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI/PET imaging.
[24391843] PLoS One 8(12):e83910 (2013)
PMC   
841
Mutation in ST6GALNAC5 identified in family with coronary artery disease.
[24399302] Sci Rep 4():3595 (2014)
PMC   
842
Drug release analysis and optimization for drug-eluting stents.
[24470792] ScientificWorldJournal 2013():827839 (2013)
PMC   
843
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
[C3860827] Indian Heart J 65(2):226-8 (2013)
PMC   
844
SKA-31, a novel activator of SK(Ca) and IK(Ca) channels, increases coronary flow in male and female rat hearts.
[23118129] Cardiovasc Res 97(2):339-48 (2013)
PMC   
845
Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
[24479706] Cardiovasc Ultrasound 12(1):5 (2014)
PMC   
846
Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.
[21735515] Catheter Cardiovasc Interv 83(2):192-200 (2014)
PMC   
847
Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
[23261783] Circ Res 112(4):675-88 (2013)
PMC   
848
Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.
[24574825] Clin Med Insights Ther 2013(5):1-14 (2013)
PMC   
849
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada.
[24493930] Clinicoecon Outcomes Res 6():49-62 (2014)
PMC   
850
Treatment of angina and microvascular coronary dysfunction.
[20842559] Curr Treat Options Cardiovasc Med 12(4):355-64 (2010)
PMC   
851
An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium.
[24575050] Front Physiol 5():44 (2014)
PMC   
852
Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease.
[23137122] Hum Gene Ther 24(2):203-8 (2013)
PMC   
853
Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases.
[24578614] Int J Med Sci 11(4):365-72 (2014)
PMC   
854
Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques.
[23473409] J Am Coll Cardiol 61(10):1041-51 (2013)
PMC   
855
Increased non-enzymatic glycation of plasma proteins and hemoglobin in non-diabetic patients with acute myocardial infarction (MI).
[24551614] J Clin Diagn Res 7(12):2692-3 (2013)
PMC   
856
Coronary artery disease in women: an unsolved dilemma.
[24578749] J Clin Med Res 6(2):86-90 (2014)
PMC   
857
Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study.
[24558424] PLoS One 9(2):e88775 (2014)
PMC   
858
MiRNAs as biomarkers of myocardial infarction: a meta-analysis.
[24533109] PLoS One 9(2):e88566 (2014)
PMC   
859
Direct comparison of cardiovascular magnetic resonance and single-photon emission computed tomography for detection of coronary artery disease: a meta-analysis.
[24520382] PLoS One 9(2):e88402 (2014)
PMC   
860
Myocardial infarction caused by pharmacological substances - case description and literature review.
[24570727] Postepy Kardiol Interwencyjnej 9(3):250-5 (2013)
PMC   
861
Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome.
[24570706] Postepy Kardiol Interwencyjnej 9(2):136-45 (2013)
PMC   
862
Lumen and calcium characteristics within calcified coronary lesions. Comparison of computed tomography coronary angiography versus intravascular ultrasound.
[24570686] Postepy Kardiol Interwencyjnej 9(1):1-8 (2013)
PMC   
863
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial.
[24398143] Trials 15():9 (2014)
PMC   
864
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.
[24562804] Eur Heart J Acute Cardiovasc Care 3(1):56-66 (2014)
PMC   
865
Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein.
[23291353] Int J Biochem Cell Biol 45(3):667-71 (2013)
PMC   
866
Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.
[23449430] J Am Coll Cardiol 61(9):971-80 (2013)
PMC   
867
Biodegradable polymer Biolimus-eluting stent (Nobori(R)) for the treatment of coronary artery lesions: review of concept and clinical results.
[24600254] Med Devices (Auckl) 7():35-43 (2014)
PMC   
868
Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts.
[23392842] Circ Res 112(6):891-9 (2013)
PMC   
869
Optimal oral antithrombotic regimes for patients with acute coronary syndrome: a network meta-analysis.
[24614630] PLoS One 9(3):e90986 (2014)
PMC   
870
Clinical implications of tenascin-C and OX40 ligand in patients with acute coronary syndrome.
[24649084] Biomed Rep 2(1):132-136 (2014)
PMC   
871
Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction.
[24522952] Neth Heart J 22(4):167-73 (2014)
PMC   
872
Contemporary cardiovascular imaging methods for the assessment of at-risk myocardium.
[24366853] J Am Heart Assoc 3(1):e000473 (2014)
PMC   
873
Assessment of the relationship between red cell distribution width and fragmented QRS in patients with non-ST elevated acute coronary syndrome.
[24621882] Med Sci Monit 20():413-9 (2014)
PMC   
874
Polymorphisms of the LTA gene may contribute to the risk of myocardial infarction: a meta-analysis.
[24642747] PLoS One 9(3):e92272 (2014)
PMC   
875
Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction.
[22713968] Clin Biochem 45(10-11):727-32 (2012)
PMC   
876
Serum ferritin-a novel risk factor in acute myocardial infarction.
[22572495] Indian Heart J 64(2):173-7 (2012)
PMC   
877
Percutaneous coronary intervention in cardiogenic shock complicating acute ST-elevation myocardial infarction-a single centre experience.
[22572491] Indian Heart J 64(2):152-8 (2012)
PMC   
878
Follow-up of CREST trial: no difference in restenosis rates between stenting and surgery.
[C3860801] Indian Heart J 64(2):217 (2012)
PMC   
879
Effect of two intensive statin regimens on progression of coronary disease.
[C3861278] Indian Heart J 64(1):116-7 (2012)
PMC   
880
Four year follow up of SYNTAX trial; optimal revascularization strategy in patients with three vessel disease and/or left main disease.
[C3861146] Indian Heart J 64(1):114 (2012)
PMC   
881
Current options for treatment of chronic coronary artery disease.
[24672695] J Thorac Dis 6(Suppl 1):S2-6 (2014)
PMC   
882
American Heart Association Scientific Sessions 2013: Agents for Hypertension, Heart Failure, and Acute Myocardial Infarction.
[24672217] P T 39(1):65-7 (2014)
PMC   
883
Trials, registries and guidelines for non-ST-elevation acute coronary syndromes.
[24259195] Neth Heart J 22(2):52-4 (2014)
PMC   
884
Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.
[24072688] Neth Heart J 22(2):55-61 (2014)
PMC   
885
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.
[24249720] Circulation 129(2):157-72 (2014)
PMC   
886
VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.
[24448490] EMBO Mol Med 6(3):307-21 (2014)
PMC   
887
The science and practice of cardiopulmonary bypass: From cross circulation to ECMO and SIRS.
[24689026] Glob Cardiol Sci Pract 2013(3):249-60 (2013)
PMC   
888
Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE.
[24689022] Glob Cardiol Sci Pract 2013(3):207-11 (2013)
PMC   
889
CABG in 2012: Evidence, practice and the evolution of guidelines.
[24688987] Glob Cardiol Sci Pract 2012(2):21-8 (2012)
PMC   
890
Distal 'buddy-in-jail' technique: a complementary 'Jail with stent' method for stent delivery.
[24552227] Acute Card Care 16(1):28-33 (2014)
PMC   
891
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
[23351464] Am J Cardiol 111(7):930-5 (2013)
PMC   
892
New insights into the management of rhythm and conduction disorders after acute myocardial infarction.
[24782917] Am J Case Rep 15():159-62 (2014)
PMC   
893
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome.
[24533683] BMC Cardiovasc Disord 14():21 (2014)
PMC   
894
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
[15905463] Circ Res 96(11):1185-92 (2005)
PMC   
895
Coronary artery anomalies presenting with ST-segment elevation myocardial infarction.
[24765348] Clin Pract 1(4):e107 (2011)
PMC   
896
Post-myocardial infarction arrhythmia risk stratification using microvolt T-wave alternans.
[24778843] Curr Health Sci J 38(2):65-8 (2012)
PMC   
897
Association between Serum Iron and the Severity of Coronary Artery Disease.
[24757630] Int Cardiovasc Res J 7(3):95-8 (2013)
PMC   
898
The prognosis of primary percutaneous coronary intervention after one year clinical follow up.
[24757614] Int Cardiovasc Res J 7(1):21-4 (2013)
PMC   
899
Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information.
[21409535] Int J Cardiovasc Imaging 27(2):299-308 (2011)
PMC   
900
Evaluation of heart function with impedance cardiography in acute myocardial infarction patients.
[24753769] Int J Clin Exp Med 7(3):719-27 (2014)
PMC   
901
Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction.
[24719720] Iran Red Crescent Med J 16(1):e9641 (2014)
PMC   
902
Coronary artery calcium score: a review.
[24693399] Iran Red Crescent Med J 15(12):e16616 (2013)
PMC   
903
Electroanatomic remodeling of the left stellate ganglion after myocardial infarction.
[22381432] J Am Coll Cardiol 59(10):954-61 (2012)
PMC   
904
Plaque hemorrhage in carotid artery disease: pathogenesis, clinical and biomechanical considerations.
[24485514] J Biomech 47(4):847-58 (2014)
PMC   
905
The predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI.
[24753830] J Cardiovasc Thorac Res 6(1):35-41 (2014)
PMC   
906
Development and course of heart failure after a myocardial infarction in younger and older people.
[24748875] J Geriatr Cardiol 11(1):1-12 (2014)
PMC   
907
Discriminant analysis between myocardial infarction patients and healthy subjects using wavelet transformed signal averaged electrocardiogram and probabilistic neural network.
[24696156] J Med Signals Sens 3(4):225-30 (2013)
PMC   
908
Improved accuracy of myocardial perfusion SPECT for the detection of coronary artery disease using a support vector machine algorithm.
[23482666] J Nucl Med 54(4):549-55 (2013)
PMC   
909
Computed tomography-based diagnosis of diffuse compensatory enlargement of coronary arteries using scaling power laws.
[23365197] J R Soc Interface 10(81):20121015 (2013)
PMC   
910
Utilization of coronary computed tomography angiography for rapid risk stratification in emergency chest pain units.
[24778667] J Res Med Sci 19(2):134-8 (2014)
PMC   
911
Radial artery: A valuable arterial conduit for coronary artery bypass grafting with precise indications, contraindications and surgical strategy.
[24719547] J Saudi Heart Assoc 26(2):127-8 (2014)
PMC   
912
Combined treatment of intractable ischemic heart disease with TML and endothelial progenitor cells-preliminary results of a therapeutic concept.
[24693007] J Stem Cells Regen Med 2(1):212 (2007)
PMC   
913
Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.
[23624705] J Thromb Thrombolysis 37(3):243-5 (2014)
PMC   
914
Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction.
[24751474] Med Sci Monit 20():660-5 (2014)
PMC   
915
Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
[24733959] Mediators Inflamm 2014():165742 (2014)
PMC   
916
Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.
[23403495] Mol Ther 21(4):725-38 (2013)
PMC   
917
Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation.
[24676100] PLoS Genet 10(3):e1004263 (2014)
PMC   
918
The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study.
[24736282] PLoS One 9(4):e93980 (2014)
PMC   
919
Clinical and angiographic outcomes after intracoronary bare-metal stenting.
[24727795] PLoS One 9(4):e94319 (2014)
PMC   
920
IL-6 signalling in patients with acute ST-elevation myocardial infarction.
[24707455] Results Immunol 4():8-13 (2014)
PMC   
921
Echocardiographic parameters as predictors of in-hospital mortality in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
[24772034] ScientificWorldJournal 2014():818365 (2014)
PMC   
922
Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial.
[24758510] Trials 15():140 (2014)
PMC   
923
Duration of dual antiplatelet treatment in the era of next generation drug-eluting stents.
[24772255] World J Cardiol 6(4):148-53 (2014)
PMC   
924
Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.
[24772254] World J Cardiol 6(4):140-7 (2014)
PMC   
925
Myocardial ischemia is a key factor in the management of stable coronary artery disease.
[24772253] World J Cardiol 6(4):130-9 (2014)
PMC   
926
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.
[24748925] World J Diabetes 5(2):115-27 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Coronary heart disease BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Coronary heart disease BASKET).php on line 92